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ABSTRACT 
 
MEGAN NUNES: Evaluating Endocrine Activity of Individual and Complex Mixtures of 
Disinfection By-Products Using Yeast Assays 
(Under the direction of Howard Weinberg) 
 
Disinfection by-products (DBPs), previously identified in disinfected surface waters, 
were evaluated individually and in mixtures for endocrine activity using the yeast estrogen 
and androgen screens. Additionally, a local surface water concentrated by reverse osmosis, 
then either chlorinated or chloraminated, was assessed for endocrine activity. Although, the 
individual and mixtures of DBP standards up to millimolar concentrations displayed no 
endocrine activity, in the presence of weakly active 4-nonylphenol, the mixtures showed 
antagonistic effects on both its estrogenicity and androgenicity with the latter enhanced at 
higher DBP concentrations. The disinfected surface water concentrates displayed antagonism 
on the estrogenicity of 4-nonylphenol and agonist effects on its androgenicity. No significant 
activity occurred when chlorinated bromide-spiked concentrate was evaluated in this manner, 
but agonist activity on 4-nonylphenol androgenicity occurred in the presence of 
chloraminated iodide-spiked concentrate. Considering these results, the effects of DBP 
mixtures on endocrine active compounds and human health cannot be ignored.  
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I. INTRODUCTION 
 
 
Drinking water treatment 
 
Prior to the early 1900s, drinking water quality was not considered as important as 
quantity. Water for drinking purposes was deemed acceptable based on aesthetic qualities 
alone. As a greater understanding of the sources and effects of drinking water contaminants 
developed, a British epidemiologist, John Snow, discovered that cholera was a waterborne 
disease (U.S. EPA, 1999). Greater concern arose regarding the presence of 
microbes/pathogens in water supplies and several techniques were developed to determine 
the sources and to remove them from the water supplies (U.S. EPA, 1999). The water 
treatment process developed through several stages to what it is today. Early treatment 
processes included boiling, charcoal filtering, straining, exposure to sunlight and slow sand 
filtration. In the early 1900s, chlorine was used for the first time to disinfect drinking water. 
Since then, additional processes have been added to the drinking water treatment process. A 
typical drinking water treatment plant uses coagulation, flocculation, sedimentation, filtration 
and disinfection (See Figure 1). The commonly-used disinfectants are chlorine, chloramine, 
UV, ozone and chlorine dioxide. As a result of Snow’s findings, the U.S Public Health 
Service established drinking water standards which marked the beginning of federal 
regulations of drinking water in the U.S. that eventually led to several federal environmental 
and health laws, one of which was the Safe Drinking Water Act (SDWA) in 1974 (U.S. EPA, 
1999). 
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With the advent of disinfection, outbreaks in waterborne diseases were reduced; 
however, due to the presence of natural organic matter (NOM), bromide and iodide in the 
water, disinfection by products (DBPs) were formed in the process. NOM is present in 
natural waters due to the decomposition of dead organisms. When chlorine, as a gas or 
sodium hypochlorite, is added to water, hypochlorous acid (HOCl) is formed which is a 
strong oxidizer that can react with chemicals in the water including NOM. This was 
discovered by Rook (1974) in the Netherlands and Bellar et al. (1974) in the United States 
when identifying the presence of trihalomethanes (THMs) in surface water that had been 
disinfected with chlorine. Since then, more than 600 DBPs have been identified in chlorine-
treated water; however, there is limited occurrence and health effects information about these 
compounds (CDC, 2012). Water suppliers face the challenge of preventing public risk from 
pathogens while controlling the level of DBPs formed in the treatment process (CDC, 2012). 
During this early period of discovery, the SDWA was implemented as a means of regulating 
the quality of the public drinking water supply by setting health-based standards which 
would protect against naturally-occurring and man-made contaminants (U.S. EPA, 1999). 
This law was later amended in 1986 and 1996.  
 
Disinfection by-products 
 
 
Occurrence of DBPs 
With the discovery of THMs in chlorine-treated water, there was an effort by the U.S. 
Environmental Protection Agency (EPA) to determine the occurrence levels of THMs 
present in the drinking water of 80 cities in the U.S. The cities were chosen to provide 
geographic diversity which would represent several raw water sources and treatment 
techniques employed. The THMs included chloroform, bromodichloromethane, 
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dibromochloromethane and bromoform (Symons et al., 1975). The results of the survey 
revealed that many of these cities tested positive for the presence of THMs in the finished 
water.  
 Following years of health effects studies, occurrence levels of a wider number of 
DBPs showed that several of them occurred at higher concentrations than had previously 
been reported (Weinberg et al., 2002). In the study, 12 plants were selected with pairs 
utilizing the same watershed for their source water and were sampled quarterly. In each 
pairing, different treatment processes including disinfectant were used. Included in the list 
were several unregulated DBPs of high priority concern for toxicity some of which were 
found at levels similar to those that were regulated. Iodo-THMs were found at levels between 
0.2 and 15 µg/L, bromine-containing nitromethanes occurred at concentrations as high as 3 
µg/L while the most mutagenic of them, MX, was found at concentrations above 100 ng/L 
and at a maximum concentration of 310 ng/L (Weinberg et al., 2002).  
 Generally, THMs and haloacetic acids (HAAs) are the most highly-occurring classes 
of DBPs; they account for approximately 25% of halogenated DBPs (Richardson et al., 
2007). The use of alternative disinfectants minimizes the formation of these classes of DBPs, 
but produces DBPs for which there is limited information regarding quantitative levels and 
health effects, and higher concentrations of the high priority DBPs; iodo-THMs were found 
in high concentration when chloramines were the primary disinfectant and halonitromethanes 
were produced at higher levels when ozonation was used prior to disinfection (Krasner et al., 
2006). 
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Regulation of DBPs 
When chloroform was identified as carcinogenic in laboratory animals by the 
National Cancer Institute, the issue of DBPs as a public health concern was initiated 
(Richardson et al., 2007). The first regulation of DBPs occurred in 1979 when the U.S. EPA 
set a maximum contaminant level (MCL) of 100 µg/L per year on total THMs i.e. the sum of 
the concentrations of chloroform, bromodichloromethane, dibromochloromethane and 
bromoform (U.S. EPA, 1979). When the Stage 1 Disinfectants (D)/DBP rule was issued in 
1998, the maximum levels for total THMs decreased to 80 µg/L. Additionally, five 
haloacetic acids (HAA5) as well as bromate and chlorite, were regulated at values of 60 
µg/L, 10 µg/L and 1000 µg/L, respectively. The current DBP regulations can be seen in 
Table 1 (U.S. EPA, 2012). 
The MCLs of the four trihalomethanes (THM4), HAA5 and bromate are monitored as 
an annual running average concentration from various points in the distribution system over a 
12 month monitoring period. The SDWA requires the U.S. EPA to set these standards while 
states must set and enforce standards that are at least as stringent as these (U. S. EPA, 1974). 
Under the SDWA, the U.S. EPA must also list unregulated contaminants on a Contaminant 
Candidate List (CCL) and, based on prioritized research and data collection about these 
contaminants, must regulate five or more contaminants on the list periodically (U.S. EPA, 
1974). Regulations are reviewed every six years and revised, as needed. Some unregulated 
compounds include DBPs such as N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine 
(NDEA), N-nitroso-di-n-propylamine (NDPA), N-nitrosodiphenylamine,                             
N-nitrosopyrrolidine (NPYR) (U.S. EPA, 2012). Although there are a few regulated DBPs, 
many of them, for which there is limited information, remain unregulated. Additionally, 
several of the studies concerning DBP health effects have been performed using individual 
 
 
5 
 
compounds whereas details on the effects of mixtures of DBPs which is what is consumed 
are minimal. Most mixture studies have tested for mutagenicity while very few of them have 
tested for carcinogenicity (Richardson et al., 2007).  
 
Brominated and iodinated DBPs 
Iodine can occur in natural waters as I
-
 and IO3
- 
(Bichsel & von Gunten, 1999). 
During disinfection, the iodide is oxidized to hypoiodous acid (HOI) which can react with 
NOM. This reaction is highly favorable in the presence of chloramine compared to chlorine 
due to the slower rate of iodide oxidation by chloramine allowing HOI to react with NOM. 
As a result, elevated levels of iodinated-DBPs occur when chloramination is used instead of 
chlorination (Bichsel & von Gunten, 1999). During the 1980s, iodomethanes were often 
identified as the cause of taste and odor problems in drinking waters. Later studies on the 
disinfection of waters high in bromide and iodide have shown the presence of DBPs such as 
iodoacetic acid, bromoiodoacetic acid, bromoiodopropenoic acid and 2-iodo-3-
methylbutenedioic acid (Weinberg et al., 2002). Iodoacetic acid has been shown to induce 
neural tube closure defects as well as other developmental abnormalities in mouse embryos     
(Plewa et al., 2004). Iodoacetic acid has also displayed higher cytotoxicity and genotoxicity 
in Salmonella typhimurium and Chinese hamster ovary cells (Plewa et al., 2004).  
In chlorinated bromide-containing waters, the main bromine species is hypobromous 
acid (HOBr) which acts chemically in a similar manner to HOCl; therefore, HOBr can also 
react with NOM to form bromine-containing DBPs. Bromine-containing haloacetic acids 
have been shown to be more cytotoxic and genotoxic than their chlorine-containing 
counterparts in Chinese hamster ovary cells (Plewa et al., 2002). 
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Health effects of DBPs 
 
Individual compounds 
DBPs have been a public health concern due to their association with cancers but 
recently, more attention has been focused on reproductive effects (Nieuwenhuijsen et al., 
2000). Human exposure to DBPs can occur through ingestion, inhalation and dermal contact 
via showering, bathing and swimming.  
Bromodichloromethane, chloral hydrate, dibromoacetic acid and dichloroacetic acid 
have led to reductions in sperm motility as well as alterations to sperm morphology in rats 
(Klinefelter et al., 1995; Linder et al., 1995, 1997). Bromodichloromethane has also produced 
renal and hepatic toxicity such as increased organ weight in rodents (Thornton-Manning et 
al., 1994). Fetal death, growth retardation and malformations in fetuses were observed when 
F344 rats were exposed to dichloroacetate (Smith et al., 1992). Neural tube and cranial 
defects, as well as abnormalities in heart morphology were observed in embryos exposed to 
haloacetic acids (Hunter et al., 1996). Exposure of rats to dichloroacetonitrile resulted in 
malformations of the urogenital system, skeletal malformations and embryo lethality (Smith 
et al., 1988); however, many of these effects occurred at very high doses of these 
compounds. 
Ebohon (2011) tested several DBPs for endocrine activity using a yeast-based assay 
and found that dichloroacetonitrile, 2-bromoacetamide, dibromoacetic acid, mucochloric 
acid, dibromoacetonitrile, trichloroacetic acid and iodoacetic acid elicited a response. These 
compounds were tested at much higher concentrations than would be found in drinking 
water. 
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Complex mixtures 
Although there is very limited data on the toxicological effects of individual DBPs, 
there is even less data on mixtures of DBPs. Human exposure to DBPs does not occur as 
individual compounds but rather as complex mixtures; therefore, it is crucial that health 
effects data on such mixtures be obtained. Andrews et al. (2004) evaluated binary and tertiary 
mixtures of dichloro-, dibromo- and bromochloro acetic acid in rat embryo culture and found 
that the effect of the mixture was additive which suggests that these compounds may have a 
similar mechanism of action. Another study by Narotsky et al. (2011) showed that pregnancy 
loss occurred in a THM4 mixture in which the concentrations of bromoform and 
bromodichloromethane were at or well below the no-effects levels for pregnancy loss.  
It is also important to evaluate real disinfected waters because they contain many 
unidentified DBPs which humans are exposed to daily. To this end, some studies 
concentrated chlorinated drinking water by reverse osmosis (RO) and the volatile DBPs 
which had been lost during the RO process were spiked back into the mixture. Sprague-
Dawley and F344 rats were exposed to this mixture and effects such as reduced pup weights 
and eye defects in litters occurred (Narotsky et al., 2012). This study was also performed to 
evaluate the suitability of testing whole mixtures in generational studies. Speth et al. (2008) 
compared concentration by RO with XAD and found that the RO process was more suitable 
for testing environmentally realistic concentrates of complex DBP mixtures. XAD has been 
used to concentrate DBPs for mutagenicity studies (Simmons et al., 2002). In this process, 
the organic components of an aqueous sample are adsorbed onto an XAD resin or 
combinations of resins and eluted with an organic solvent which is subsequently evaporated. 
The compounds left behind are redissolved in solvent and then evaluated                  
(Simmons et al., 2002). The appeal of using XAD as a concentration method is due to little 
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interference by inorganic compounds; however, during the process, the hydrophilic and 
volatile components of the sample are lost (Simmons et al., 2002). RO produces a larger 
volume of sample and does not require solvent extraction. Miltner et al. (2008) treated the 
same source water using different disinfection techniques and, after concentrating by RO 
(Speth et al., 2008), compared the concentration of DBPs to the toxicological effects of the 
mixtures produced. In a related study by Richardson et al., (2008) nonregulated DBPs were 
detected in these treated waters, some at higher and some at lower concentrations than 
regulated DBPs in the same class. Also, most of these DBPs were stable during the animal 
studies performed. Through analysis of the treated waters for mutagenicity in Salmonella 
(Claxton et al., 2008) the chlorinated waters were determined to be more mutagenic than the 
same waters following preozonation. 
 
Endocrine disruption 
 
The endocrine system is made up of glands and hormones which are produced by the 
pituitary gland, thyroid, pancreas, adrenal glands and male and female gonads. This system 
helps in the development, growth, reproduction and behavior of humans and animals      
(U.S. EPA, 1997). The hormones that are produced such as 17-β-estradiol and testosterone 
are transported through the bloodstream from these glands to other parts of the body where 
they bind to receptors that are specific to these hormones. Endocrine disruption can occur if 
chemicals block the receptor, thereby preventing binding of the hormone, or the chemical can 
mimic the hormone and bind to the receptor which causes an over-response to the stimulus. 
Endocrine disrupting compounds can also cause the endocrine system to over or under-
produce hormones. The threat of endocrine disruption is that it can lead to toxic outcomes 
such as cancer and adverse reproductive effects (U.S. EPA, 1997). During the 1990s, certain 
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chemicals were thought to disrupt the endocrine system of humans and wildlife; therefore, in 
1996, an amendment was made to the SDWA which required the EPA to screen pesticide 
chemicals for estrogenic activity and also gave them authority to screen other chemicals that 
might possess estrogenic, androgenic and thyroid hormone activity (U.S. EPA, 2012). The 
Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) was formed 
during this time to advise the EPA on developing methods for screening and selecting 
chemicals for testing. A tiered approach for the Endocrine Disruptor Screening Program 
(EDSP) was developed based on the recommendations provided. Tier 1 screening includes a 
selection of assays that would determine whether identified substances would interact with 
the estrogen, androgen or thyroid systems (U.S. EPA, 2011). Tier 2 testing would determine 
whether a chemical would cause endocrine disrupting effects via any of the hormonal 
systems listed previously, determine the effects to the organism and establish a dose response 
relationship between the chemical and the observed effects (U.S. EPA, 2011).  
Several studies have shown that chemicals can cause endocrine disruption in 
laboratory animal subjects. Additionally, there has been evidence of endocrine disruption in 
wildlife exposed to such chemicals in the environment. Vitellogenin was found in the plasma 
of male fish which had been exposed to sewage effluent (Purdom et al., 1994; Jobling et al., 
1998; Nakari, 2004). This protein is typically synthesized in the liver of female fish in 
response to estradiol stimulation (Purdom et al., 1994). Kuiper et al. (1998) showed that 
phytoestrogens, estrogens produced by plants, had higher binding affinities than industrial 
chemicals such as nonylphenol, bisphenol A and o, p’-DDT which are weakly estrogenic; 
however, these estrogen-mimics are still considerably less potent than the endogenous 
counterparts. The yeast estrogen screen (YES) was used in conjunction with the H295R 
steroidogenesis assay to determine the endocrine disrupting potential of river sediments in 
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Germany and several of these samples gave a positive response (Grund et al., 2011). 
Pharmaceuticals and pharmaceutical mixtures present in aquatic systems have displayed 
weak estrogenic activity in the YES assay (Fent et al., 2006). Rajfer et al. (1986) showed that 
ketoconazole, an anti-fungal medicine, lowered serum testosterone levels by inhibiting the 
enzymes needed for biosynthesis of this hormone.  
Public water supply is affected by potential endocrine disruptors because drinking 
water may contain chemicals and pesticides that may possess endocrine disrupting activity. 
 
Structure of endocrine active compounds  
 
The estrogen receptor (ER) is able to bind with a wide variety of compounds    
(Kuiper et al., 1998). The structural features of a compound are not sufficient to predict its 
estrogenic potential (Fent et al., 2006); however, many estrogenic compounds that bind to the 
receptor are found to contain alkylphenols in which the position and branching of the alkyl 
group affects estrogen activity (Routledge & Sumpter, 1997). Alkyl groups in the para 
position to the –OH group are more estrogenic than alkyl groups in the meta and ortho 
positions. In androgen receptor (AR) binding, hydrogen bonding and hydrophobic 
interactions are significant (Fang et al., 2003). It was found that a 3-keto group and a 17β-OH 
group on a compound are important for AR binding. These provide ‘anchors’ for a ligand to 
attach to the receptor site (Fang et al., 2003).  
 
Concern about endocrine disruption of DBPs 
 
DBPs have been suspected of interfering with the reproductive system by causing 
decreased testosterone levels and sperm motility as well as alteration to sperm morphology 
(Klinefelter et al, 1995; Linder et al., 1995, 1997). Exposure of laboratory animals to 
dibromoacetic acid has revealed increased levels of estrogen (Balchak et al., 2000; Goldman 
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& Murr, 2003). These findings have led the EDSTAC to recommend that DBPs be included 
in the list of chemicals tested for endocrine disrupting effects. There is currently no 
regulation of DBPs either as individual compounds or mixtures, with respect to endocrine 
disruption.  
A few studies have shown that by-products of chlorination exhibit an estrogenic 
effect (Itoh et al., 2009; Cargouet et al., 2006). Itoh et al. (2009) used the MVLN assay, a 
mammalian in vitro assay which is not on the Tier 1 screening battery, to show that the 
estrogenic activity of surface water increased after chlorination and that residual chlorine, 
below 30 mg/L, did not affect the assay. Cargouet et al. (2006) demonstrated weak estrogenic 
activity of 2-chlorophenol using the MELN assay; however, several other chlorination by-
products such as bromodichloromethane, bromoform, trichloroacetic acid, 
dichloroacetonitrile, trichloroacetonitrile, dibromochloromethane, dichloroacetic acid, chloral 
hydrate and dichloromethane were not found to be estrogenic using this assay. Wu et al. 
(2009) used a yeast two-hybrid assay to show that chlorination increased the antiestrogenic 
activity but decreased the estrogenic activity of wastewater. Another study found that the 
estrogenic activity of chlorinated wastewater was decreased when compared to the 
wastewater in the absence of chlorination using the MCF-7 assay which is a mammalian in 
vitro assay (Schiliro et al., 2009). The study also found that THM values were higher when 
the effluent was chlorinated. Based on these findings they concluded that there was no 
relationship between estrogenic activity and THMs. 
 
Bioassays used to test for endocrine disruption 
There are several in vitro and in vivo bioassays that are used to test for estrogenic and 
androgenic effects of chemicals. Some in vitro assays include competitive ER/AR binding, 
 
 
12 
 
cell proliferation and reporter gene assays. Reporter gene assays utilize yeast and mammalian 
cell lines and can test for estrogenic and androgenic activity; these include yeast-based assays 
(YES and YAS), and mammalian cell assays such as T47D-KBluc and the MDA-kb2 
(Zacharewski, 1997; Wilson et al., 2004). In vitro are useful in defining mechanisms of 
action of potential estrogenic or androgenic compounds whereas in vivo assays provide 
information on overall health effects of the compounds (Bolger et al., 1998). Each assay has 
its advantages and disadvantages.  
 
Competitive binding assays  
These assays test the binding of a competitive ligand for the estrogen or androgen 
receptor site; however, they cannot distinguish between agonists and antagonists as both of 
these classes of chemicals bind to the ER (Zacharewski, 1997; Wilson et al., 2004; Hartig et 
al., 2008). Hartig et al. (2008) developed a method that utilizes chimpanzee-derived AR 
which is almost identical to the human AR. Additionally, because a ligand can bind to a 
receptor site does not mean that it can determine the estrogenicity or androgenicity of a 
substance; the ligand must be able to maintain nuclear receptor occupancy so that an adverse 
response may be initiated (Zacharewski, 1997). Murk et al. (2002) used the ER binding assay 
to detect the estrogenic activity in wastewater and surface water; however, many of the 
samples were below the detection limit of this assay.  
 
Cell proliferation assays 
 
These assays use estrogen responsive MCF-7 or T47D human breast cancer cells. The 
MCF-7 assay was established by the Michigan Cancer Foundation (Graham et al., 1986). 
After a 6-day incubation period in the presence of suspected estrogenic compounds, the 
number of cells produced is compared. This assay is fairly simple but does not clearly 
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demonstrate that a substance is estrogenic as mitogens can also influence cell proliferation 
(Zacharewski, 1997; Wilson et al., 2004). Mitogens are chemicals that are not estrogenic but 
can induce mitosis and lymphocyte transformation.  
This assay has been used to evaluate environmental samples. Korner et al. (2001) 
analyzed composite effluent samples from municipal sewage treatment plants in Germany 
and found that 17 of the 18 samples analyzed induced proliferation in a concentration 
dependent manner.   
 
Yeast estrogen/androgen screen (YES/YAS) 
 
In this assay, the yeast cells Saccharomyces cerevisiae have been stably transfected 
with the gene for human ERα and the human AR. The ER consists of ERα and ERβ, but the 
ERα is found in the uterus and mammary gland whereas the ERβ is found in other systems 
such as the central nervous, cardiovascular and immune as well as in the bone, kidney and 
lungs (Gustafsson, 2000). This yeast also contains an expression plasmid which carries the 
estrogen and androgen responsive elements (ERE and ARE) which regulate the expression of 
the lac-Z reporter gene (Routledge & Sumpter, 1996; Sohoni & Sumpter, 1998). This lac-Z 
gene encodes for the enzyme β-galactosidase. When an active ligand binds to the receptor, 
this activates the lac-Z gene thereby resulting in its expression to produce β-galactosidase. 
This enzyme is secreted into the medium to which the yeast is exposed and metabolizes the 
substrate such as o-nitrophenyl-β-galactopyranoside (oNPG) for estrogenicity and 
chlorophenol red-β-D-galactopyranoside (CPRG) for androgenicity. The oNPG is 
metabolized to a yellow phenolic compound whose absorbance is measured at 450 nm and 
the CPRG is metabolized to a red product whose absorbance is measured at 540 nm. The 
absorbance at 450 nm measures the amount of o-nitrophenol that is produced from the 
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enzyme catalysis of oNPG. This gives an indication of the amount of β-galactosidase enzyme 
produced which reflects the activation of the ER. The same is true for the measurement at 
540 nm in the YAS assay which measures the amount of chlorophenol red produced from the 
enzyme catalysis of CPRG. The YES assay has been widely used to detect estrogenic activity 
of individual compounds as well as environmental samples (Bistan et al., 2012; Murk et al., 
2002). Bistan et al. (2012) have shown the applicability of the YES in detecting estrogenic 
activity of influent and effluent from a Slovenian municipal wastewater treatment plant. 
Murk et al. (2002) also used the YES assay to evaluate the estrogenic potency of wastewater, 
sludge and surface water. The yeast-based assays have been useful in evaluating endocrine 
activity in toxic samples because they produce less cytotoxicity than in the mammalian cell 
assays. Although the YES assay has limited sensitivity and can lead to false negatives, 
published research demonstrates its use to qualitatively obtain rapid results (Dobbins et al., 
2008). The YAS assay has not been used as frequently but has been able to detect androgen 
activity of individual compounds (Sohoni & Sumpter, 1998). The yeast based assays do not 
give an accurate indication of permeability of compounds across mammalian cell membranes 
due to the presence of the yeast cell wall (Baker, 2001). These assays are not listed on the 
screening assays recommended by the EDSTAC, but they are relatively cheap and simple 
and provide a good preliminary indication of endocrine active compounds which can then be 
tested using mammalian cell assays. Absolute confirmation and relevance of findings from 
yeast-based assays towards human health require the analysis of samples using mammalian 
cell based assays.  
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Research objectives 
The aim of this project was to address the following questions using yeast-based assays: 
1) Do RO concentrated surface waters treated with chlorine or monochloramine possess 
endocrine disrupting activity?  
2) Do RO concentrated surface waters spiked with bromide and iodide and treated with 
chlorine and monochloramine possess endocrine disrupting activity?  
3) Are the yeast based assays suitable for testing these real water complex mixtures?  
4) Is RO concentrated water a suitable medium in which to test the complex mixtures of 
DBPs? 
The specific research objectives were as follows: 
1) To confirm the findings of Ebohon (2011) regarding the individual DBPs in the YES 
assay. 
2) To compare the endocrine disrupting activity of DBPs formed during chlorination to 
those formed during chloramination by disinfecting RO concentrate under the 
following conditions: 
a. sufficient contact time with the disinfectant so as to leave a residual as close to 
zero as possible, 
b. spiking iodide into the RO concentrate prior to disinfecting with chloramine, 
c. spiking bromide into the RO concentrate prior to disinfecting with chlorine, 
d. determining endocrine disrupting activity by the YES and YAS assays and 
comparing the responses. 
3) To ensure that the RO concentrate was not toxic to the yeast and did not possess any 
endocrine activity by testing the concentrate using the yeast assays. 
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4) To ensure that the chlorine and chloramine residuals were not toxic to the yeast and 
did not affect the yeast efficacy or nonylphenol activity. 
5) To ensure that the iodide and bromide ions were not toxic to the yeast and did not 
affect the yeast efficacy or nonylphenol activity. 
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II. MATERIALS & METHODS 
Chemicals & Reagents 
Raw and settled water was collected from the Orange Water and Sewage Authority’s   
surface water treatment plant (Carrboro, NC) and their organic carbon concentrated using a 
custom-built portable reverse osmosis (RO) filtration unit as described by Lyon et al. (2012). 
The concentrates were stored at 4°C in acid-washed glass amber bottles until required for 
use. These waters are referred to as RO concentrates in this study. Laboratory grade water 
(LGW) was prepared using a Dracor Water System unit (Durham, NC) which removes 
residual disinfectants, reduces the total organic carbon (TOC) to < 0.2 mg/L C and removes 
ions to 18 MΩ. Dichloroacetonitrile (98%) was purchased from Crescent Chemical (Islandia, 
NY). 4-nonylphenol (99%), bromodichloromethane (98%), trichloroacetonitrile (98%) and            
2-bromoacetamide (98%) were purchased from Acros Organics (Fair Lawn, NJ).                  
4-nonylphenol is a mix of isomers and is referred to as nonylphenol in this thesis. 
Dibromoacetic acid (90%), trichloroacetic acid (99%), mucochloric acid (99%), 
dibromoacetonitrile (95%) and estradiol were purchased from Aldrich (St. Louis, MO).        
3-bromopropionitrile (98%) was purchased from Alfa Aesar (Ward Hill, MA). The EPA 
551B Halogenated Volatiles Mix in acetone and contained 2000 µg/mL each of 
bromochloroacetonitrile, dibromoacetonitrile, dichloroacetonitrile, 1,1-dichloro-2-propanone, 
1,1,1-trichloroacetone, trichloroacetonitrile, trichloronitromethane was purchased from 
Supelco (Bellefonte, PA). Bromide and iodide spikes were prepared using sodium bromide 
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(100%) from Fisher Scientific (Fair Lawn, NJ) and potassium iodide (99.7%) from Baker 
(Phillipsburg, NJ). Sodium hypochlorite (5.65-6% w/w, laboratory grade) was purchased 
from Fisher Scientific. Sodium thiosulfate (0.0995-0.1005 N) was purchased from Fisher 
Scientific. Ammonium chloride (99.8%) used in the preparation of monochloramine was 
purchased from Mallinckrodt (Hazelwood, MO). Ethanol (200 proof) was obtained from 
Decon Labs (King of Prussia, PA). The reagents used for the yeast estrogen screen (YES) 
and the yeast androgen screen (YAS) assays are described in Appendices A and B.  
 
Methods 
The YES and YAS assays were used to measure the estrogen and androgen responses, 
respectively, of the test substances. The YES assay was adapted from the method by 
Routledge and Sumpter (1996) with modifications previously implemented in our laboratory 
(Ebohon, 2011). The YAS assay was adapted from the method by Sohoni and Sumpter 
(1998), with modifications where applicable. The yeast cells had been stably transfected with 
the human estrogen (YES assay) and human androgen (YAS assay) receptors, the estrogen 
and androgen response elements (ERE and ARE), and the Lac-Z gene which produces the 
enzyme β-galactosidase. 
In the early parts of this study, estradiol was used as a positive control for the YES 
method; however, the EC50 was several orders of magnitude lower than that expected for the 
DBPs tested (Ebohon, 2012).  The EC50 value is an estimate of the concentration of a 
chemical that elicits an effect in 50% of the population being studied (Krieger, 2001). In a 
dose response curve, it is the concentration of chemical that elicits a response halfway 
between the baseline and the maximum response (Mutolsky & Christopoulos, 2004). A 
switch was subsequently made to nonylphenol as a positive control as its dose response curve 
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would be in a concentration range closer to that of the DBPs eliciting an effect in the assays. 
Individual compounds, as well as a mixture of DBPs obtained by disinfecting RO 
concentrate, were tested by the yeast assays. In earlier evaluations of DBPs using the YES 
assay, the dose response curves occurred at much higher concentrations than would be found 
in drinking water (Ebohon, 2011). By scaling up the organic carbon to disinfectant dose ratio, 
it was hoped that elevated levels of DBPs would make it easier to detect differences in the 
activity of the water treated with the different disinfectants at equivalent doses.  
         The data obtained from the assays were analyzed using GraphPad Prism 4 software 
(Version 4.03, La Jolla, CA) and dose response curves were plotted.          
 
YES assay 
The assay adapted from Routledge and Sumpter (1996) is described in Appendix A. The 
yeast cells were maintained by streaking agar plates monthly.  An isolated yeast colony was 
taken from an agar plate and cultured in a 50 mL Falcon tube containing 7 mL URA-TRP 
media for 24 hours on a shaker table at 200 rpm at 30°C. The yeast culture was diluted with 
YPS media to obtain an absorbance of 0.06 – 0.09 absorption units at 600 nm when 100 µL 
was placed into a well of a flat bottom plate and read using a plate reader. The absorbance of 
0.06 – 0.09 was demonstrated to give the best dose response curve for the positive control.  
For samples prepared in 10% ethanol, an 8 channel multipipettor was used to add 100 µL 
of 10% ethanol to each well in columns 2-12 of a 96 deep well plate. If the sample was 
prepared in another matrix, 100 µL of this matrix was added instead of 10% ethanol.  
200 µL of positive control (2.50E-04 M nonylphenol which corresponds to 55 mg/L) 
freshly-prepared in 10% ethanol was added to the two wells of the first row and in the first 
column. This solution was prepared from a stock solution of approximately 4.54E-02 M      
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4-nonylphenol in ethanol. 200 µL of sample to be tested was also added to two wells in the 
first column. A 1:2 serial dilution was performed across the wells by taking 100 µL from a 
well and transferring it to the well in the next column. 100 µL was removed from the second 
to last well, after diluting, and discarded as waste. The last column contained the negative 
control which is the matrix in which the sample was prepared. See Figure A.1 in Appendix A 
for a diagram of the plate setup. 
The 8 channel multipipettor was used to add 300 µL of yeast dilution to each well 
containing the solutions described above in the 96 deep well plate. The plate was covered 
with plate sealing film and placed on a shaker table at 200 rpm in a 30°C incubator for three 
days.  
After the three day incubation period, 50 µL of the Z-buffer and 2-mercaptoethanol 
solution followed by 400 µL of the Z-buffer, 2-mercaptoethanol, ortho-nitrophenyl-β-D-
galactopyranoside and 10% sodium dodecyl sulfate solution were added to each well. The 
plate was covered and incubated on a shaker for 20 minutes at the same conditions described 
in the previous paragraph.  
After this time period, 200 µL of 1M sodium carbonate was added to each well and the  
plate centrifuged for 10 minutes at 3000 rpm. After coming to rest, the 8 channel 
multipipettor was used to transfer 100 µL of the supernatant to the wells in the same position 
of a 96 well flat bottom plate and the absorbance was read at 450 nm on a plate reader. After 
reading the plate, the yeast was resuspended in the deep well plate with the multichannel 
pipettor, and 100 µL of the suspension was transferred to the wells in the same position of a 
different 96 well flat bottom plate. The absorbance of this plate was read at 600 nm to 
measure cytotoxicity.  
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The corrected absorbance at 450 nm for each sample dilution is obtained by subtracting 
the absorbance of the negative control for the corresponding sample from the absorbance of 
the test substance. The dose response curves, for some of the tested compounds, were 
obtained by plotting the corrected absorbance against the log molar concentration. The other 
dose response curves were obtained by plotting the percent maximum response against the 
log molar concentration. The dose response curves were used to obtain the EC50 value.    
 
YAS assay 
 
The assay adapted from Sohoni and Sumpter (1998) is described in Appendix B. The  
yeast cells were maintained by streaking agar plates monthly.  An isolated yeast colony was 
taken from an agar plate and cultured in a 50 mL Falcon tube containing 7 mL growth media 
for 48 hours on a shaker table at 200 rpm at 30°C. After incubation, the yeast culture was 
diluted with the growth media to obtain an absorbance of 0.1 – 0.2 absorbance units at      
620 nm when 100 µL was placed into a well of a flat bottom plate and read with a plate 
reader. The absorbance of 0.1-0.2 was demonstrated to give the best dose response curve for 
the positive control. Chlorophenol red-β-D-galactopyranoside (CPRG) solution was added in 
the proportion of 0.5 mL CPRG to 50 mL of yeast dilution and was used as the yeast assay 
solution. 
For samples prepared in 100% ethanol, an 8 channel multipipettor was used to add      
100 µL of 100% ethanol to each of the 1 mL wells in a 96 deep well plate, except for those in 
the first column.  
200 µL of positive control (6.81E-03 M nonylphenol, which corresponds to 1500 mg/L, 
in 100% ethanol) was added to two wells in the first column. The 6.81E-03 M nonylphenol 
solution was prepared in 100% ethanol, from a 4.54E-02 M stock solution in ethanol, and 
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stored at -15°C. If there was a shift in the EC50 value from previously obtained values when 
testing this solution, a new 6.81E-03 M 4-nonylphenol solution would be prepared. A 1:2 
serial dilution was performed across the wells by taking 100 µL from each well and 
transferring it to the well in the next column. 100 µL was removed from the second to last 
well, after diluting, and discarded to waste. The last column of the plate contained the 
negative control which was the yeast/CPRG solution. See Figure B.1 in Appendix B for a 
diagram of the plate setup. Aliquots of 10 µL were removed from each well using a 
multichannel pipettor, and added to the wells in the same position on a 96 well flat bottom 
plate and the ethanol was allowed to evaporate in a fume hood at ambient temperature. After 
complete evaporation of the ethanol, 200 µL of the yeast/CPRG solution was added to each 
of the dry wells. The plate was then covered with plate sealing film, placed on a shaker at 
200 rpm in an incubator at 30°C for 3 minutes and then removed from the shaker and kept in 
the incubator for 24 hours. After the incubation period, the absorbance at 540 nm of each 
well was read and repeated at 620 nm to correct for turbidity due to the yeast. A deep-red 
color signifies higher positive activity while the negative controls appear lighter orange in 
color due to slight background production of β-galactosidase. The corrected absorbance is 
calculated as the difference between the absorbance at 540 nm for the test chemical and the 
value obtained when the blank absorbance at 620 nm is subtracted from the absorbance at 
620 nm for the test chemical. The method described here was used as the method control to 
ensure that the assay was functioning properly. The method was adjusted for each experiment 
run; the adjustments are described in the following sections and in Appendix B. The dose 
response curves, for some of the tested compounds, were obtained by plotting the corrected 
absorbance at each serial dilution against the log molar concentrations of the test chemical at 
that dilution. The other dose response curves were obtained by plotting the percent maximum 
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response against the log molar concentration. The point on the curve furthest to the right 
represents the response for the highest concentration of chemical. 
 
Optimizing yeast concentration 
 
YES and YAS assays using two concentrations of the yeast solution and                    
4-nonylphenol were also performed to optimize the methods for most sensitivity as measured 
by absorbance. 
 
Testing RO concentrates 
RO had been previously used to concentrate NOM (Simmons et al., 2008). Undiluted 
and diluted RO surface water concentrates and RO settled water concentrate were tested for 
estrogenic and androgenic activity as well as cytotoxicity, using the YES and YAS assays 
with nonylphenol spiked in. In the YES assay, the nonylphenol was spiked into a mixture of 
an RO concentrate sample/10% ethanol to obtain a concentration of 2.50E-04 M 
nonylphenol. The assay was performed according to the method in Appendix A, using         
4-nonylphenol (6.78E-05 M to 6.63E-08 M) as the positive control. 4-nonylphenol was 
diluted across the wells in the RO concentrate/10% ethanol solutions. The RO concentrates 
were also tested by themselves for endocrine activity and their respective TOC 
concentrations were kept constant. In the YAS assay (see Appendix B), after serial dilution 
of 4-nonylphenol (6.81E-03M) and evaporation of the ethanol, 100 µL of RO concentrate 
was added to the designated wells before adding 200 µL of yeast solution. The positive 
control was 4-nonylphenol (2.27E-04 M to 2.22E-07 M) in LGW where 100 µL LGW was 
added to each of the dry wells after serial dilution of 4-nonylphenol (6.81E-03M) and 
evaporation of ethanol. 
 
 
 
24 
 
Testing individual DBPs & standard mixtures 
 Several DBPs were tested individually using the YES and YAS assays. These DBPs 
were prepared, in 10% ethanol, at the working concentrations listed in Appendix C. The 
assays were performed as described in Appendices A and B. 
 Due to the nature of the YAS assay in which the ethanol must be evaporated, several 
of the volatile DBPs could not be tested using this procedure; therefore, a modification was 
made to the method in which the DBPs were prepared in a lower concentration of ethanol. 
Prior to performing the assay with this modification, a maximum concentration of ethanol in 
water that could be tolerated by the yeast was determined. This allowed for the DBPs to be 
prepared at a higher concentration which was more likely to initiate a response in this less 
sensitive assay. The ethanol was diluted, in nonylphenol prepared in 10% ethanol, across a 
row of a 96 deep well 1 mL plate while the nonylphenol concentration was held constant in 
each of the wells. The absorbance of each of the wells were obtained at 450 and 600 nm and 
compared to the absorbance expected at the respective concentration of nonylphenol. 
 In addition to testing individual DBPs, a standard mixture of 7 DBPs in the EPA 
551B Halogenated Volatiles Mix was tested. For the YES assay, the mix was diluted, with 
10% ethanol, to concentrations in which each component was present at 100, 50 and            
10 mg/L. Serial dilutions of each of these solutions were performed across the plate in 
acetone/10% ethanol. The negative control for this assay was acetone/10% ethanol. 
Additionally, the EPA 551B mix was tested for antagonistic effects on the nonylphenol. 
Samples were prepared in acetone/10% ethanol into which nonylphenol and the EPA 
standard mix were both added. 4-nonylphenol was serially diluted across the plate in standard 
mix/10% ethanol. The positive control for this experiment was 4-nonylphenol in 
acetone/10% ethanol. For the YAS assay, the standard mix was diluted with LGW, to 
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concentrations in which each component was present at 75 and 25 mg/L. Serial dilutions 
were performed across the plate in acetone/LGW. Antagonistic effects on 4-nonylphenol 
androgenicity were also evaluated. After serial dilution of 4-nonylphenol (6.81E-03 M) in 
ethanol and evaporation of the ethanol, 100 µL of the diluted standard mix, at 75 and           
25 mg/L, was added to each of the dry wells. 
 
Testing chlorine and chloramine residuals 
The effects of chlorine and chloramine concentrations up to those targeted as 
residuals in the disinfection experiments (i.e. ≤ 5 mg/L as Cl2) were tested on the yeast 
assays. The procedures for YES and YAS were performed as described in Appendices A and 
B with the chlorine and chloramine solutions used, instead of LGW, to prepare the 
nonylphenol (2.50E-04M) test samples. For the YES assay, the positive control was             
4-nonylphenol (6.24E-05 M to 6.09E-08 M) in 10% ethanol. The test samples were prepared 
by spiking 4-nonylphenol into 10% ethanol/chlorine or chloramine solution to achieve a 
concentration of 2.50E-04 M. 4-nonylphenol was serially diluted across the plate in the 10% 
ethanol/chlorine or chloramine solution. For the YAS assay, 4-nonylphenol was serially 
diluted across the plate in ethanol and after evaporation of the ethanol, 100 µL of chlorine or 
chloramine solution was added to the dry wells. For the positive control, 100 µL LGW was 
added to the dry wells.   
The chlorine and chloramine solutions were also tested by themselves for estrogenic 
and androgenic activity. 
 
 
 
 
 
26 
 
Testing bromide and iodide concentrations 
Bromide at concentrations of 1.5 mg/L and 0.5 mg/L and iodide at of 0.5 mg/L and 
0.1 mg/L were used in a subset of disinfection experiments. To ensure that they did not affect 
the yeast efficacy and 4-nonylphenol dose response curve, the YES and YAS assays were 
performed as described in Appendices A and B with the bromide and iodide solutions used, 
instead of LGW, to prepare the nonylphenol test samples. For the YES assay, the positive 
control was 4-nonylphenol (1.23E-04 M to 1.21E-07 M) in 10% ethanol. The test samples 
were prepared by spiking 4-nonylphenol into 10% ethanol/bromide or iodide solution to 
achieve a concentration of 4.92E-04 M. 4-nonylphenol was serially diluted across the plate in 
the 10% ethanol/bromide or iodide solution. For the YAS assay, 4-nonylphenol was serially 
diluted across the plate in ethanol and after evaporation of the ethanol, 100 µL of bromide or 
iodide solution was added to the dry wells. For the positive control, 100 µL LGW was added 
to the dry wells. In both assays, the ion solutions were tested, in the absence of                     
4-nonylphenol, for endocrine activity. 
 
TOC 
The TOC levels of the RO raw and settled water concentrates were measured after 
substantial dilution in LGW using a Shimadzu TOC-VCPH Total Organic Carbon Analyzer 
and were found to be 121 mg/L C and 26 mg/L C, respectively after back calculation from 
the results of the dilutions. The Standard Operating Procedure can be found in Appendix D.  
 
Preparation of RO concentrates with added bromide and iodide 
Bromide and iodide were spiked into the RO surface water concentrate so that when 
chlorine and chloramine would be added elevated levels of bromine- and/or iodine-
containing DBPs would be produced. These have been shown to be geno- and cytotoxic in 
 
 
27 
 
Chinese hamster ovary (CHO) cells (Plewa et al., 2002) and since the source water used in 
this study does not contain high levels of these ions (Weinberg et al., 2002) would likely be 
absent in the disinfected unspiked waters. The bromide was added to the concentrate as 
sodium bromide with a desired concentration of 1.5 mg/L. A 100 mL stock solution of    
1000 mg/L sodium bromide as Br
-
 was prepared in LGW which was then diluted to 1.5 mg/L 
by spiking in 375 µL of the stock solution into a 250 mL volumetric flask containing the RO 
surface water concentrate with a TOC 50 mg/L C. The iodide was added to the concentrate as 
potassium iodide with a desired concentration of 0.1 – 0.5 mg/L as I-. A 100 mL stock 
solution of 1000 mg/L as I
-
 was prepared in LGW which was then diluted to 0.5 mg/L by 
spiking in 125 µL of the stock solution into a 250 mL volumetric flask containing the RO 
surface water concentrate with a TOC 50 mg/L C. 
These spiked waters were treated with chlorine and chloramine and their impact on 
the efficacy of the yeast and the effect on nonylphenol estrogen and androgen activity were 
tested by preparing the nonylphenol working solution in these treated waters using the 
procedures described in Appendix C.  
 
Disinfection & chlorine demand test 
The sodium hypochlorite (NaOCl) was standardized before use according to the 
standard operating procedure (SOP) in Appendix E. The SOP for monochloramine 
preparation can be found in Appendix F.  
Chlorine and monochloramine were added to separate samples of the diluted RO 
surface water concentrate (TOC = 50 mg/L C) at doses of 5.9, 12.2 and 24.3 mg/L as Cl2 and 
0.50, 1.00 and 1.99 mg/L as Cl2, respectively in volumetric flasks. The samples were inverted 
three times to mix, transferred headspace-free to 20 mL amber vials, and stored at a room 
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temperature of 21°C. During the reaction time, the free and total residuals were measured 
with a Hach Chlorine Pocket Colorimeter after 24, 48, 120 and 216 hours. This disinfectant 
demand experiment was performed to determine the dose of disinfectant that leaves as close 
to zero residual as possible and used Hach methods 8021 and 8167 (Hach Co., Loveland, 
CO) for free and total chlorine, respectively in which the sample was poured into 10 mL 
quartz glass vials and the DPD reagent powder pillows were added. If the residual was above 
the range for the free and total chlorine (0-2.00 mg/L Cl2), the sample was diluted with 
LGW, and the residual was determined after back calculation from the dilution.  
Monochloramine residuals were measured using a Hach DR/890 Datalogging 
Colorimeter according to Hach method 10171 (Hach Co., Loveland, CO) in which the 
sample was poured into 10 mL plastic vials and the monochlor-F reagent powder pillows 
were added. The range for the monochloramine residual is 0-4.50 mg/L Cl2.  
 
Preparation of disinfected samples 
   The diluted RO surface water concentrate and the spiked samples were treated with 
chlorine and chloramine separately for two weeks. The surface water concentrate was used so 
as to generate the highest amount of DBPs. A chlorine dose of 45 mg/L as Cl2 and 
monochloramine doses of 2 and 12 mg/L were added to the RO surface water concentrate in 
separate 25 mL volumetric flasks and inverted three times to mix. These were the highest 
doses that gave as close to zero residual as possible in the disinfectant demand test. The 
samples were transferred, headspace-free, to 20 mL amber vials which were used to measure 
the chlorine and chloramine residuals. They were stored at 15°C in a temperature-controlled 
room for a period of two weeks. After the reaction time, these samples were tested on the 
YES assay. Another batch of RO surface water concentrates were disinfected with chlorine 
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doses of 45 and 55 mg/L as Cl2 and monochloramine doses of 2 and 12 mg/L as Cl2 and 
stored at 15°C in a temperature-controlled room for a period of six weeks. After the reaction 
time, they were tested on the YES and YAS assays. 
In the disinfection of the bromide- and iodide-containing surface water concentrates, 
only chlorine was used to disinfect the bromide-containing water and only monochloramine 
was used to disinfect the iodide-containing water. Sufficient chlorine and chloramine was 
added to account for their reaction with the ions as well as with the NOM in the concentrate. 
A chlorine dose of 58 mg/L as Cl2 was used and the chloramine dose was the same as used 
previously, 12 mg/L as Cl2.   
After a period of two weeks, the residuals were measured, to ensure they were as 
close as possible to zero, using the Hach Colorimeter and the samples were then tested using 
the yeast assays. Nonylphenol was used as the positive control and the effect of the 
disinfected samples on the nonylphenol dose response curve was measured. In the YES 
assay, the working solution of nonylphenol (2.50E-04 M) was prepared in 10% ethanol using 
the appropriate disinfected samples instead of LGW (See Appendix C). These disinfected 
samples in 10% ethanol, without added nonylphenol, were also used as a negative control in 
the YES assay. In the YAS assay, the working solution of nonylphenol (6.81E-03 M) was 
prepared in 100% ethanol (See Appendix C). The disinfected samples, without added 
nonylphenol, were also used as a negative control in the YAS assay.  
All disinfected concentrates were tested by themselves for endocrine activity. 
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III. RESULTS & DISCUSSION 
 
 
Optimizing the yeast assays 
 
Prior to evaluating endocrine activity, optimization of the yeast assays, with                    
4-nonylphenol (1.13E-04 M to 1.11E-07 M) in 10% ethanol, was undertaken by testing two 
different concentrations of yeast. The methods for the yeast assays are in Appendices A 
(estrogen screen) and B (androgen screen). The actual concentration of yeast was unknown 
but the absorbance value of the yeast solution reflects the concentration.  Figures 2 & 3 show 
the dose response curves obtained in the YES assay when two different concentrations of 
yeast were tested. The yeast solution with an absorbance value of 0.086 gave a better dose 
response curve at the 4-nonylphenol concentration range tested. Because of the absence of 
saturation at the highest concentrations when the dose response curve is not well-defined as 
in Figure 3, Graphpad overcalculates the EC50 whose literature value for 4-nonylphenol is 
7.0E-06M (Beck et al., 2006). These results demonstrate that the yeast solution would give 
an optimum response at an absorbance of approximately 0.09 absorbance units. During this 
study, the yeast solutions used had absorbance values between 0.06 and 0.09. In Figure 4, the 
highest concentration of 4-nonylphenol tested was 5.90E-05 M and a well-defined dose 
response curve was obtained; therefore, this demonstrates that it is not necessary to use a 
higher concentration of 4-nonylphenol. Furthermore, using much higher concentrations of   
4-nonylphenol would not be feasible due to its limited solubility. In water it is 2.73E-05 M 
which has a log10 value of -4.56 (ECB, 2002).    
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Figures 5 & 6 show the dose response curves obtained in the YAS assay when two 
different concentrations of yeast were tested. The 4-nonylphenol solution was prepared at a 
concentration of 1000 mg/L (4.54E-03 M) in ethanol but the highest concentration tested was 
2.27E-04 M as a result of dilution after the addition of 200 µL of yeast. These results 
demonstrate that the yeast solution would give the best response at an absorbance of 
approximately 0.10 absorbance units. During this study, the yeast solutions used had 
absorbance values between 0.1 and 0.2 absorbance units. Although the EC50 values for the 
solutions are very close (2.22E-04 M in Figure 5 and 2.67E-04 M in Figure 6), there is less 
error between the readings obtained from the yeast solution with an absorbance value of 
0.114 absorbance units. There is no EC50 value for 4-nonylphenol androgenicity in the 
literature. Figure 5 is also a representative dose response curve for the method positive 
control in which 200 µL of yeast solution was added after evaporation of the ethanol as 
described in the “Materials & Methods” chapter and in Sohoni and Sumpter (1998). This 
positive control was run in each of the experiments to ensure that the method was functioning 
properly. The experimental positive controls differ according to experimental objective and 
were used for better evaluation of the tested samples. 
 
Testing individual DBPs 
   
Using the optimized yeast solution absorbance values, individual DBPs, listed in the 
‘Materials & Methods’ chapter, were tested for endocrine disruption. The endocrine response 
was compared to that of 4-nonylphenol as a positive control in this study since it is a weak 
estrogenic and androgenic compound, thereby providing dose response curves in a 
concentration range more relevant to the DBPs. Furthermore, the DBPs were tested at much 
higher concentrations than would be present in drinking water but the results would give an 
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indication of whether these compounds would trigger a response mechanism in the yeast. 
Also, the results would allow a prioritization of DBPs for future testing by mammalian cell 
assays. Although some of the DBPs tested had shown estrogenic activity using the YES 
assay in a previous study (Ebohon, 2011), they did not show any response in either of the 
yeast assays in this current work across the same concentration ranges. Estradiol, whose dose 
response curve is shown in Figure 7, was run as the positive control at the same time that the 
DBPs in Figures 8-12 were run. It was decided after this experiment that 4-nonylphenol 
would be a more practical positive control. The attempted dose response curves obtained 
from the YES assay can be seen in Figures 8-12 for dichloroacetonitrile, 
bromodichloromethane, dibromoacetic acid, 3-bromopropionitrile and 2-bromoacetamide. 
These curves were almost flat lines which mean that no positive estrogenic response was 
detected at the concentration ranges tested. This could be due to the lack of estrogenic 
activity of the compound or its cytotoxicity to the yeast. To determine whether the 
compounds showed cytotoxic effects, the absorbance of the wells containing the yeast and 
the DBP was measured at 600 nm in the YES assay and the values are presented in Table 2. 
These values would give an indication of yeast cytotoxicity if they are much lower than the 
values of the negative control, which, in this experiment was 10% ethanol. The cytotoxicity 
column in Tables 2 to 5 is the difference between the negative control’s absorbance and the 
absorbance of the sample at 600 nm represented as a percent of the negative control’s 
absorbance. In some instances, the absorbance value was higher than the negative control 
which could have been due to pipetting error. This method of evaluating yeast cytotoxicity 
has been used previously (Hamblen et al., 2003); however, it is not stated at what difference 
in absorbance values cytotoxicity can be considered. Most of the DBPs do not show 
cytotoxic activity except for 2-bromoacetamide and dichloroacetonitrile at their highest 
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concentrations in the YES assay. However, they do not exhibit endocrine activity even at the 
lower concentrations suggesting that these compounds are not endocrine active at the same 
concentration range that Ebohon (2011) had tested. Dichloroacetonitrile, dibromoacetic acid 
and 2-bromoacetamide had been tested previously and produced a positive estrogen response 
in the YES assay (Ebohon, 2011). In Ebohon’s work (2011), 2-bromoacetamide caused 
cytotoxicity at the two highest concentrations, but at the other tested concentrations, it 
displayed estrogenic activity. These results were not confirmed in this current study at the 
same concentrations tested.  The DBPs were also tested in the YAS assay (see method in 
Appendix B) in a 12% ethanol solution because this was the highest concentration of ethanol 
that could be used without being toxic to the yeast. In the YAS assay, the compound is 
typically prepared in 100% ethanol and this is allowed to evaporate from the wells of the 
assay plate (see “Materials & Methods” chapter); however, some of the DBPs are volatile 
and this method would not be suitable for testing them. The method was adjusted to account 
for this; therefore, the DBPs were prepared in the highest concentration of ethanol that would 
be tolerable to the yeast. The positive control used in this experiment was 4-nonylphenol in 
12% ethanol (see Figure 13).The dose-response curves obtained from the YAS assay can be 
seen in Figures 14-18. A higher concentration of ethanol had to be used in the YAS rather 
than the YES assay because a higher concentration of 4-nonylphenol was needed due to its 
weak androgenic activity. The DBPs do not display androgen activity at any of the 
concentrations tested. Dibromoacetic acid in Figure 15 shows a slight increase in the 
absorbance values but this difference was determined not to be significant by using a student 
t-test (p-value > 0.05). In Figure 16, the difference in the absorbance values of 2-
bromoacetamide at the four highest concentrations (2.42E-03 M to 3.03E-04 M) and  those 
between 1.51E-04 M  and 1.89E-05 M, were determined not to be significant (p-value > 
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0.05) by a student t-test; however,  cytotoxicity could have contributed to the lower 
absorbance values at the higher concentrations. If cytotoxicity had not occurred there may 
have been a slight androgenic response of this compound. The absorbance values at 620 nm, 
which give an indication of yeast cytotoxicity, can be seen in Table 3. In this instance, 
cytotoxic effects limited the possibility of testing the DBP at a higher concentration. 
Therefore, even if the compound was at or below the no-observed-effects concentration 
(NOEC), increasing the concentration would not have been useful. Small differences in yeast 
cell density/turbidity between the control and the test compound could also be due to 
pipetting error. It is possible that yeast cells could have stuck to the inside of the pipet tips or 
the volume of yeast delivered to the wells was not exactly the same. Perhaps another test for 
yeast cytotoxicity could be implemented in the future for confirmation. Hu et al, (2002) used 
a yeast two-hybrid system to measure the decrease in    β-galactosidase activity when the 
yeast was exposed to the sample. This result was compared to the β-galactosidase activity in 
the absence of a compound. Although a different strain of yeast and assay were used, the 
method may be applicable to the yeast assays employed in this study. The absence of an 
endocrine response by the targeted DBPs in both YES and YAS assays cannot be used to 
dismiss their potential endocrine disruption in mammalian cells. They simply do not elicit a 
response in the yeast based assays. The yeast cell wall could serve as an impediment to 
chemicals trying to cross the membrane which might not replicate an effect in mammalian 
cells (Baker, 2001). Clearly, in vitro and in vivo assays using such cells would need to be 
performed to confirm these results in mammalian cell lines or animal studies. 
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Testing standard mixtures 
  
In an attempt to determine the endocrine activity of simple mixtures of DBPs, an EPA 
standard mixture of halogenated volatile DBPs was tested for endocrine activity. The method 
for the YES assay is in Appendix A. This mixture contains seven DBPs 
(bromochloroacetonitrile, dibromoacetonitrile, dichloroacetonitrile, 1,1-dichloro-2-
propanone, 1,1,1-trichloroacetone, trichloroacetonitrile, trichloronitromethane) each at a 
concentration of 2000 µg/mL in acetone. This mixture was diluted, with 10% ethanol, to 
working concentrations of 100 and 10 mg/L (4.76E-03 M and 4.76E-04 M) of each 
component. The actual highest concentrations tested were 1.19E-03 M and 1.19E-04 M, 
respectively, due to dilution when the yeast solution was added. The negative control used in 
this experiment was 10% ethanol with acetone spiked in at the same concentrations as was 
present in the prepared samples. The mixture did not display estrogenic activity in the YES 
assay (see Figures 19 & 20); however, antagonistic effects might be occurring. Cytotoxicity 
may also have been the reason that no activity occurred. Table 4 shows the absorbance values 
at 600 nm which were lower than the negative control at the respective concentrations. For 
the more concentrated DBP mixture, the two highest concentrations may have produced 
cytotoxic effects which could have contributed to the lack of endocrine activity at these 
concentrations but at lower concentrations there was still no activity even with no 
cytotoxicity effect.  
The EPA standard DBP mixture was also tested for androgenic activity in the YAS assay. 
This test was carried out slightly different to the assay described in Appendix B due to 
volatility of the DBPs. The standard mixture was diluted, with LGW, to concentrations of 25 
and 75 mg/L (1.19E-03 M and 3.57E-03 M, respectively) of each component. The working 
solutions were prepared at these concentrations but the actual highest concentrations tested 
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were 3.97E-04 M and 1.19E-03 M, respectively due to dilution when the yeast solution was 
added. Each of these solutions was diluted across separate wells of a 96 deep well plate in a 
LGW/acetone mixture. The positive control was 4-nonylphenol in the range 2.27E-04 M to 
2.22E-07 M with 100 µL LGW/acetone added after evaporation of the ethanol (see Figure 
21). The negative control was the LGW/acetone mixture. Neither of the DBP mixture 
solutions possessed androgenic activity (see Figures 22 & 23) when compared to                     
4-nonylphenol (Figure 21). Cytotoxic effects were also considered and Table 5 shows the 
absorbance values at 620 nm which were lower than the negative control at the 
concentrations tested. For the more concentrated DBP mixture, the absorbance value of the 
sample was much lower than the negative control at the highest concentration only and this 
may be due to cytotoxicity. For the less concentrated DBP mixture, even at the highest 
concentration, the absorbance value was not much lower than the negative control (see Table 
5); therefore, cytotoxic effects probably did not occur.  
 
Investigating antagonism 
 
 A nonylphenol working standard was prepared in 10% ethanol and the EPA standard 
mix was spiked in to achieve a concentration of 10 mg/L (4.76E-04 M) of each component. 
This solution was tested to determine whether the mixture of DBPs affected the yeast 
efficacy or the nonylphenol activity in the YES assay. 4-nonylphenol was serially diluted in 
10% ethanol/acetone or 10% ethanol/DBP mixture; therefore, the DBP mixture concentration 
was constant across the plate. The negative control in this experiment was 10% ethanol with 
acetone spiked in at the same concentrations as was present in the sample. The positive 
control was 4-nonylphenol in 10% ethanol/acetone. The absorbance values were normalized 
and the relative absorbance calculated relative to the 4-nonylphenol control (Hamblen et al., 
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2003). Figure 24 was plotted using the relative absorbance or percent maximum response 
against the log of the molar concentration. For this and all following analyses, the top and 
bottom constraints were set at the highest percent response per data set and at 0%, 
respectively for the YES assay. In the YAS assay analyses, the top constraint was set at the 
highest percent response per data set but no constraint was set for the bottom because the 
lowest absorbance obtained in the YAS was approximately one absorbance unit. For both 
types of assays, the EC50 values were calculated in Graphpad. To determine whether there 
was some significance to the difference in the absorbance values, statistical analysis was 
performed using a statistical program, R version 2.15.1 (Vienna, Austria). For several of the 
curves, the lowest analyte concentrations at which the absorbance values were essentially 
baseline values, and there was no difference between them, were eliminated from the 
analysis and a regression model was used to predict the average absorbance. This prediction 
was based on the log concentration and the average absorbance values as well as a dummy 
variable for the types of samples tested. The data was analyzed in this manner because there 
were only two absorbance values at each concentration and this analysis would give more 
definitive results. The model calculated the p-value based on all concentrations considered in 
a curve. Statistical significance of the difference between the absorbance values occurs when 
the p-value < 0.05. In Figure 24, all the points on the dose response curve were statistically 
analyzed because the absorbance values at the lower concentrations were not the same even 
though they were baseline values. Baseline values are those absorbances that would be 
measured in the absence of an estrogenic or androgenic compound. Also, a different 
regression model was used for these curves in which all concentrations were considered 
because of the sigmoidal shape. An example calculation of the p-value is in Appendix H. 
Figure 24 is the dose response curve of the serial dilution of 4-nonylphenol in 10% 
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ethanol/acetone and also in 10% ethanol with the DBP mixture spiked in to achieve a 
concentration of 10 mg/L (4.76E-04 M) of each component. According to Figure 24, there 
may have been a slight antagonistic effect on 4-nonylphenol in the nonylphenol/DBP 
mixture. A previous study showed that when several xenoestrogens were combined at levels 
below their individual no-observed-effect concentrations (NOEC), the activity of E2 was 
greatly enhanced (Rajapakse et al., 2002). Although the effect in that study is the opposite of 
what was observed in this current study, the important issue is that the combination of 
xenoestrogens at concentrations below their individual NOECs affected the activity of the 
estrogenic compound. The differences in the absorbance values were determined to be 
significant; however, the EC50 values (see Table 6) for both curves are very close but there is 
a slight difference due to the shifting of the curve. This suggests that the EC50 values are not 
a good indicator of antagonism and were, therefore, not used to compare the curves. 
Cytotoxic effects of the yeast may have been present at the highest concentration of the DBP 
mixture which could have contributed to the lower absorbance value (see Table 4), but at 
lower concentrations where there was no cytotoxicity, antagonistic effects were still 
observed.  
Antagonistic effects were tested in the YAS assay by adding 100 µL of the diluted EPA 
standard DBP mixtures (25 and 75 mg/L) to the dry wells after the evaporation of the ethanol 
in the wells containing 4-nonylphenol. 4-nonylphenol was first serially diluted across the 
wells in 100% ethanol. The dose-response curves are shown in Figure 25 which appear to 
show some antagonistic effects of the DBP mixture on the androgenic activity of                   
4-nonylphenol. Also, there is more of an antagonistic effect when a higher concentration of 
the DBP mix is used reflected in a higher EC50 value (see Table 7) and a p-value < 0.05 for 
absorbance which means that the difference between absorbance values of the positive 
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control and the higher concentration DBP mixture is significant. The positive control for this 
experiment was 4-nonylphenol in LGW/acetone. 100 µL of LGW/acetone was added to the 
dry well after evaporation of ethanol. The negative control was LGW/acetone. The lower 
absorbance values of the more concentrated DBP mixture could be due to slight cytotoxic 
effects at the highest concentration (see Table 5), but antagonistic effects are still observed at 
the lower concentrations. All of the concentrations on the dose response curve were used in 
the R analysis. 
 
Testing RO concentrates 
 
Before preparing and testing complex mixtures of DBPs created by disinfecting RO 
concentrate, preliminary tests were performed to ensure that the RO concentrate was a 
suitable medium for testing disinfected waters using the yeast assays.  If the individual 
components of the disinfected media did not affect the dose response curve of the 4-NP then 
any effect on its dose response by the disinfected water would be due to the DBPs produced 
during the disinfection process.  
The TOC of the RO surface and settled water concentrates were determined to be              
121 mg/L C and 26 mg/L C, respectively. The diluted and undiluted RO surface water 
concentrate (TOC = 50 and 121 mg/L C respectively), as well as the RO settled water 
concentrate, were tested for cytotoxic effects to the yeast and effects on the nonylphenol 
activity in the YES and YAS assays. The dose response curves shown in Figures 26 & 27 
together with the EC50 values for 4-nonylphenol in Tables 8 & 9 reveal that the RO waters 
did not affect the activity of nonylphenol. The absorbance values in Tables 10 & 11 were not 
much lower than the negative control although some were higher perhaps due to pipetting 
error. These waters were not toxic to the yeast. Any slight difference in the absorbance 
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values is not significant; therefore, the NOM did not contribute to estrogenic or androgenic 
activity in these assays and could be a suitable medium to use to test complex mixtures of 
DBPs. The positive control in the YES assay experiment was 4-nonylphenol in 10% ethanol 
and the negative controls were 10% ethanol/RO concentrate. 4-nonylphenol was serially 
diluted across the wells in 10% ethanol or 10% ethanol/RO concentrate; therefore, the 
concentration of RO concentrate was constant across the wells. In the YAS assay experiment, 
the positive control was 4-nonylphenol in LGW and the negative control was LGW or RO 
concentrate. 100 µL of LGW or RO concentrate, respectively was added to the dry wells 
after evaporation of ethanol. 4- nonylphenol was first serially diluted across the wells in 
100% ethanol. The 6 highest concentrations in Figure 26 and the 7 highest concentrations in 
Figure 27 were used in the R analysis. The RO concentrated waters were tested without 
nonylphenol in the solution and they did not give a positive response in these assays at the 
highest concentration of TOC tested. In Tables 12 & 13 the average corrected absorbances 
were much lower than the value at the highest concentration of the positive control and were 
essentially baseline values. Only the surface water RO concentrate was used in the 
disinfection experiments. 
 
Testing chlorine and chloramine residuals 
 
Similar tests were carried out on chlorine and chloramine residuals at concentrations of         
5 mg/L in 10% ethanol in the YES assay and 2 and 5 mg/L respectively in LGW in the YAS 
assay. These concentrations did not affect yeast efficacy or nonylphenol activity; therefore, if 
a lower concentration of residual was present in the treated waters this would not have had 
deleterious effects on the assay. The dose response curves obtained from these tests are 
shown in Figures 28 & 29 respectively for the YES and YAS assays and the EC50 values are 
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in Tables 14 & 15. There is no significant difference between the corrected absorbances in 
these residual concentrations and the control. In the YES assay, the positive control was 4-
nonylphenol in 10% ethanol and the negative controls were 10% ethanol/residual. 4-
nonylphenol was serially diluted across the wells in 10% ethanol or 10% ethanol/residuals. In 
the YAS assay, the positive control was   4-nonylphenol in LGW and the negative control 
was LGW/residual. After serial dilution of 4-nonylphenol in 100% ethanol and evaporation, 
100 µL of LGW or residual solution was added to the dry wells. In Figures 28 & 29 the 4 
highest concentrations were considered in the R analysis. Tables 16 & 17 show the 
absorbance values at 600 and 620 nm for the YES and YAS assays, respectively at the 
highest concentration of residual tested. These values do not indicate cytotoxicity because the 
absorbance values are only slightly lower or higher than the negative control. In Tables 18 & 
19 the average corrected absorbances were much lower than the value at the highest 
concentration of the positive control and were baseline values.  All of these results 
demonstrate that no estrogenic or androgenic response occurred at the highest concentrations 
of the residuals tested.  
 
Testing bromide and iodide concentrations 
 
Bromide (at 0.5 mg/L and 1.5 mg/L) and iodide (at 0.5 mg/L) were tested in the same 
manner as disinfectant residuals and the dose response curves shown in Figures 30 & 31 
show no effect on 4-nonylphenol. At the lower concentration of bromide, there seems to be 
some difference in the absorbance values at the highest nonylphenol concentration in the 
YES assay, but there is no significant difference between these values and the control         . 
Although there is a difference in the absorbance values for iodide in the YES assay, 
especially at the highest concentration of nonylphenol, this difference in not significant. The 
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positive control in this experiment was 4-nonylphenol in 10% ethanol and the negative 
controls were 10% ethanol or 10% ethanol/ion solution. 4-nonylphenol was serially diluted 
across the wells in 10% ethanol or 10% ethanol/ion solution. In the YAS assay, iodide 
concentrations of 0.5 and 0.1 mg/L were tested for yeast efficacy and nonylphenol activity 
but do not display any effects based on the dose response curves (see Figure 31). 
Furthermore, statistical analyses show that any differences between absorbance values of the 
samples and the control are not significant. The EC50 values for both assays are in Tables 20 
& 21. These concentrations of ions were used to reflect the highest concentrations found in 
natural waters (Lyon et al., 2012; WHO, 1996). In this experiment, the positive control was 
4-nonylphenol in LGW and the negative control was LGW or ion solution. In Figures 30 & 
31 the 4 highest concentrations were used in the R analysis. No cytotoxic effects occurred 
due to the presence of the ions (see Tables 22 & 23). Neither estrogenic nor androgenic 
activity was observed in the assays when these ions were tested at their highest 
concentrations in the absence of nonylphenol (see Tables 24 & 25). The average corrected 
absorbances were much lower than the value at the highest concentration of the positive 
control and were baseline values. The highest concentration of bromide added to the RO 
concentrate, before disinfection with chlorine, was 1.5 mg/L; therefore, any bromide present 
after disinfection would be lower than this concentration due to the reaction with free 
chlorine. 
In the preliminary tests, for each set of curves, the EC50 values are very close to the 
positive control; however, the absorbance values were compared for significance due to the 
lack of confidence in the EC50 values when well-defined curves are not obtained. In Figure 
30, there is a slight difference in the EC50 values of the nonylphenol in the presence of       
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0.5 mg/L iodide and 0.5 mg/L bromide compared to the control (see Table 20) but the 
difference in the absorbance values is not significant.   
 
Testing disinfected samples 
 
 
Disinfected RO concentrates 
 
Once the preliminary tests were carried out, the diluted surface water RO concentrates   
(TOC = 50 mg/L C) were treated separately with various doses of chlorine and 
monochloramine. Chlorine was added as NaOCl (stock concentration was ~53357 mg/L as 
Cl2) at doses of 20, 25, 35 and 45 mg/L as Cl2 while monochloramine (stock concentration 
was ~1500mg/L as Cl2) was added at doses of 2, 5, 8 and 12 mg/L as Cl2. After a two week 
reaction time, the residuals were measured (see Tables 26 & 27). It was desired that the 
residuals be as close as possible to zero so that the use of a quenching agent would not be 
necessary. The RO concentrates treated with a chlorine dose of 45 mg/L as Cl2 and 
monochloramine doses of 2 and 12 mg/L as Cl2 were tested using the YES assay with          
4-nonylphenol in LGW as the positive control and LGW or disinfected concentrate as the 
negative control. The highest dose of chlorine was tested because the residual was close to 
zero and a higher level of DBPs would have been present. The two chloramine doses were 
tested because the chloramine residual values were different but the free chlorine residuals 
were approximately the same for both doses. The treated waters were analyzed with and 
without 4-nonylphenol spiked in to achieve a concentration of 94 mg/L (4.28E-04 M).   
Figure 32 shows the dose-response curves obtained in the YES assay and Table 28 shows the 
EC50 values. In this experiment, the concentration of 4-nonylphenol varies while the 
concentration of DBPs produced was constant. 4-nonylphenol was serially diluted across the 
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wells in the disinfected samples. Based on the curves, there seems to be some antagonistic 
activity on the estrogenicity of 4-nonylphenol, at its highest concentrations, due to exposure 
of the yeast to the treated waters. The reason for the absence of an effect on 4-nonylphenol at 
the lower concentrations is unclear.   The significance of these differences was determined by 
performing statistical analyses on the absorbance values. In Figure 32 the 4 highest 
concentrations were used in the R analysis. The p-value obtained for the analysis on the 
positive control and the treated waters < 0.05 which means that the difference between the 
absorbance values of the treated waters and the control is significant; however, there is no 
significant difference in absorbance values between the treated waters . The pH of the treated 
waters was not tested, but a pH less than 6 can cause the chloramine to change to 
dichloramine according to the reaction below (Kirmeyer, 2004) 
2NH2Cl             NH3 + NHCl2 
 Although the p-value suggests that there is no significant difference between the treated 
waters, these results would need to be confirmed with further tests in which the pH of the 
disinfected RO concentrate would be tested after reaction and adjusted if necessary to ensure 
that the pH is between 6 and 8. This would ensure that monochloramine is present in the 
solution. Cytotoxic effects did not occur (see Table 29) and when these waters were tested in 
the absence of 4-nonylphenol, no estrogenic activity was observed (see Table 30). The 
average corrected absorbances were much lower than the value at the highest concentration 
of the positive control and were baseline values. 
Another batch of diluted surface water RO concentrate (TOC = 50 mg/L as C) was 
disinfected with chlorine (45 and 55 mg/L as Cl2) and chloramine (2 and 12 mg/L as Cl2) and 
were analyzed by the yeast assays after six weeks reaction time. The measured residuals can 
be found in Tables 31 & 32. The 45 and 55 mg/L doses left the same free chlorine residual so 
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the higher dosed sample was tested because this was likely to produce a higher level of 
DBPs. When the samples for yeast analysis were prepared, the volume of ethanol added to 
the solution was chosen to produce a final concentration of 10% ethanol. The dose response 
curves are shown in Figure 33 for the YES assay and Table 33 shows the EC50 values. The 
positive control in this experiment is 4-nonylphenol in 10% ethanol and the negative control 
was 10% ethanol or 10% ethanol/disinfected concentrate. The 4 highest concentrations were 
used in R analysis. The curves do not show any significant difference in the responses and 
the p-value > 0.05. Although different chlorine doses were used in the two experiments 
(Figures 32 & 33), the goal was to compare the endocrine effect of disinfected waters.  A 
higher level of DBPs may have been produced in the second experiment, but the extended 
holding time may have caused losses in DBPs that explains the difference in dose response 
curves compared to the first experiment. It is possible that these DBPs would have 
contributed to the antagonistic effect seen in the previous test (Figure 32). No cytotoxic 
effect occurred (see Table 34) and when these waters were tested in the absence of               
4-nonylphenol, no estrogenic activity was observed (see Table 35). The average corrected 
absorbances were much lower than the value at the highest concentration of the positive 
control and were baseline values. 
The waters from the second experiment were also tested in the YAS assay using 
nonylphenol (1500 mg/L working solution) with 100 µL LGW added to the dry wells as the 
positive control and the negative controls were LGW and disinfected concentrates. Figure 34 
shows the dose response curves obtained and some enhanced activity of the nonylphenol, 
particularly from chlorine at the higher concentrations of 4-nonylphenol suggesting possible 
agonistic effects. Table 36 shows the EC50 values for these samples. At higher concentrations 
of 4-nonylphenol, the chlorine-treated RO concentrate gave a higher response than the 
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positive control and the chloramine-treated concentrate suggesting that the chlorine-treated 
concentrate produces greater agonistic effects on the androgen activity of 4-nonylphenol. At 
lower concentrations of 4-nonylphenol, the two types of disinfectants produced responses 
similar to each other but higher than the positive control. Overall though, chlorine shows the 
greater effects. All the dose concentrations were considered in the R analysis. The p-value of 
< 0.05 suggests that the difference between the treated waters and the control is significant, 
while the difference between the treated waters is not.  Although the p-value of < 0.05 
demonstrates that the difference is significant, the differences in the absorbance values are 
not great. There is no minimum value for the differences which would indicate significance. 
The treated waters did not cause cytotoxicity to the yeast (see Table 37) but when these 
waters were tested in the absence of nonylphenol, there was no positive androgenic response 
(see Table 38). 
 
Disinfected spiked RO concentrates 
 
The treated waters were tested when the free chlorine residual was as close as possible to 
zero (see Table 39 for residual values). A chlorine dose of 58 mg/L as Cl2 was used to 
account for the added bromide which becomes HOBr and can react with NOM. The 
chloramine dose of 12 mg/L as Cl2 was sufficient to account for the added iodide which 
would react with NOM in the form of HOI. The results of disinfecting bromide- and iodide- 
spiked RO concentrate on the estrogenic activity of 4-nonylphenol using the YES assay are 
shown in Figure 35 with 4-nonylphenol in 10% ethanol as the positive control and the 
negative control was 10% ethanol or 10% ethanol/disinfected spiked concentrates. The EC50 
values are shown in Table 40. The chloraminated iodide-spiked water did not have an effect 
on the nonylphenol at any concentration. It would have been interesting to compare the 
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effects of the disinfected unspiked waters against the disinfected spiked waters; however, 
these waters were not tested on the same day and other factors could have affected the results 
on the different days. In the same figure, the response of the chlorinated bromide-spiked 
water can be seen. At the highest concentration of nonylphenol, the chlorinated water 
displayed slight antagonistic effects, but the difference in the absorbance values was not 
significant (p-value > 0.05). Also, there was no significant difference between the treated 
spiked waters. The three highest concentrations were considered in the R analysis. In the 
YAS assay, both types of treated spiked waters displayed agonistic effects on 4-nonylphenol. 
The dose response curves can be seen in Figure 36. The positive control was 4-nonylphenol 
(2.27E-04 M to 2.22E-07 M) in LGW and the negative control was LGW or disinfected 
spiked concentrates. 100 µL of LGW or disinfected samples was added to the dry wells. 
Greater agonistic effects were seen in the chloraminated water which implies that the iodine-
containing DBPs have a greater androgenic effect than those which are bromine-containing 
and while the difference in absorbance values between the chlorinated water and the control 
is not significant, that between the chloraminated water and the control is (p-value < 0.05). 
The 4 highest dose concentrations were used in the R analysis. In testing the treated waters in 
this experiment and in the previous one (results shown in Figure 34), 100 µL of the treated 
water was added to each of the dry wells in the designated row. The EC50 values for the YAS 
assay are shown in Table 41.  
In both the YES and YAS assays, there were no cytotoxic effects (see Tables 42 & 43) 
but the disinfected spiked RO concentrate displayed neither estrogenic nor androgenic effects 
by themselves (see Tables 44 & 45). These waters could not have been compared to the 
disinfected unspiked waters because the treated spiked and unspiked waters were tested on 
the yeast assays on different days. .    
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IV. CONCLUSIONS & LIMITATIONS OF THE STUDY 
 
The individual DBPs tested displayed neither estrogenic nor androgenic activity in the 
yeast assays up to their limit of solubility in the millimolar range. This limits the use of these 
assays as a prescreening tool. The yeast possesses a cell wall which could serve as an 
impediment to compounds trying to cross the membrane compared to mammalian cells.       
2-bromoacetamide showed slight cytotoxicity at the highest concentrations in both the YES 
and YAS assays while dichloroacetonitrile showed slight cytotoxicity at the highest 
concentration in the YAS assay. This may have contributed to a lower endocrine response 
than produced in the work of Ebohon (2011). At the lower concentrations where no 
cytotoxicity occurred, these DBPs did not give positive responses in this study as they did in 
the work of Ebohon (2011) possibly due to reduced yeast sensitivity.  
The mixture of DBPs also did not show any endocrine activity but, in the presence of 4-
nonylphenol, slight antagonistic effects were observed on nonylphenol activity in both the 
estrogen and androgen assays.   
Prior to evaluating activity of disinfected RO concentrates, the chlorine and chloramine 
residuals, bromide and iodide ions and the RO surface water concentrate were shown not to 
affect yeast efficacy or nonylphenol activity. There may have been slight antagonistic 
activity in the YES assay in the presence of iodide at 0.5 mg/L but this activity was not 
significant (p-value > 0.05). 
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When the treated RO concentrates were tested after two weeks of disinfection, 
antagonistic effects on the estrogenic activity of 4-nonylphenol were observed in both the 
chlorine and chloraminated waters. This was most pronounced in the chloramine treated 
water at a dose of 2 mg/L as Cl2 although, according to the p-value, the difference between 
the absorbance values of this chlorine dose and the other doses of disinfectants is not 
significant (p-value > 0.05). When another batch of disinfected waters was tested six weeks 
after disinfection, no significant effects on the estrogenic activity of 4-nonylphenol were 
observed, but agonistic effects on its androgenic activity were noted. The difference between 
the estrogenic effects for the two experiments could be due to the loss of volatile DBPs 
during the longer disinfection period which means that the volatile DBPs could have 
contributed to the earlier antagonistic effect on the estrogenicity of 4-nonylphenol, while the 
non-volatile DBPs would have contributed to the agonistic effect on its androgenicity. This 
would have to be confirmed with further tests and analysis of the treated waters for their DBP 
types and concentrations.  Any agonistic and antagonistic effects on an endocrine active 
compound could have implications for human health because the same effects could occur on 
natural hormones and affect the functioning of the endocrine system (Kolle et al., 2010). 
  When the disinfected bromide-spiked RO concentrate was evaluated, a small 
antagonistic effect was observed on the estrogenicity of 4-nonylphenol; however, a greater 
effect was observed in the unspiked chlorinated concentrate. This could be due to a mixture 
effect of the bromine-containing and non-bromine-containing DBPs which caused a smaller 
antagonistic effect than the DBPs in the unspiked concentrate. In the YAS assay, the 
bromine-containing DBPs showed agonistic effects on 4-nonylphenol but the effect was not 
significant. 
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The iodine-containing DBPs likely produced during the chloramination of the iodide-
spiked RO concentrate, did not cause any change to the dose-response curve of                      
4-nonylphenol in the YES assay but the same water did show significant agonistic effects on 
4-nonylphenol in the YAS assay. Also, a greater agonistic effect was observed when iodide 
was spiked in and chloraminated, thereby suggesting that iodine-containing DBPs are greater 
androgen agonists than the non-iodine-containing DBPs. Analysis should be carried out on 
the treated waters to confirm the presence of bromine- and iodine-containing DBPs. 
During the assay incubation period, volatile DBPs may have been lost which could have 
affected the results. Precautions were taken to minimize the loss of volatile DBPs such as 
performing the assay on ice and using Alumna Seal to cover the assay plates; however, it is 
not certain what minimum contact time is required between the yeast and the DBPs for an 
effect to occur.  
In the statistical analyses, the data set analyzed was small (n = 2 replicates). For each 
curve, only two absorbance values were plotted for each serial dilution of the sample tested.  
One experiment that could be performed is to test the activity of the nonyphenol in the 
presence of the individual DBPs to determine whether the activity is influenced by individual 
compounds as well as mixtures. Additionally, the effects of the compounds and mixtures on 
natural hormones could be evaluated. It could also be useful to test treated spiked and 
unspiked RO concentrate on the same day so that the results can be compared.  
Another experiment that could be performed is to disinfect the undiluted RO concentrate 
which will have a higher TOC value (121 mg/L C). This would hopefully create a higher 
level of DBPs in solution and possibly produce a more pronounced effect in the assays. 
One goal of the study was to compare chlorinated with chloraminated RO concentrate, 
that had been disinfected to leave equivalent residuals, for differences in estrogenic and 
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androgenic responses and to assess the applicability of the assays for such tests. These yeast- 
based assays are simple tests which can be used for preliminary screening of potential 
endocrine disruptors and can provide insight when comparing different treatment techniques 
of drinking water. They are relatively simple, inexpensive assays which can be employed 
before using more complex and expensive mammalian cell assays. The yeast had been 
transfected with the human estrogen/androgen receptor which eliminates any interference 
from other receptors which may be present in a mammalian cell such as receptors for other 
steroids, peptide hormones and growth factors (Routledge & Sumpter, 1996). Additionally, 
the yeast cells are more resilient than mammalian cells and can tolerate higher concentrations 
of chemicals without exhibiting cytotoxic effects thus allowing for a wide range of doses to 
be examined limited mostly by their solubility in the medium.  
Another goal was to confirm the results obtained by Ebohon (2011) in which several 
DBPs were found to be estrogenic when compared to estradiol. These results were not 
confirmed in this study and the reasons for this are unclear.  
The reproducibility of the YES and YAS assays has been demonstrated in the study. The 
EC50 values of the positive controls have been consistent during the course of the study. 
Furthermore, these assays have been shown to be applicable to the testing of real water 
mixtures of DBPs. Neither the NOM nor the residuals present exhibited cytotoxic effects to 
the yeast or affected nonylphenol activity. Additionally, a response was seen when the 
treated waters were tested on the assays in the presence of nonylphenol. These results should 
be confirmed with mammalian cell in vitro assays.   
Although no response was observed when the standard and complex DBP mixtures were 
tested by themselves, they affected the estrogenicity and androgenicity of 4-nonylphenol 
activity in its presence. This raises the issue of whether DBP mixtures, which would be found 
 
 
52 
 
in drinking water, could lead to endocrine disrupting effects of hormones which are found in 
humans or other endocrine compounds found in animals. The study by Rajapakse et al. 
(2002) encountered similar mixture effects when they tested the effect of a mixture of 
xenoestrogens on estradiol. The xenoestrogens were combined, at concentrations below their 
individual “no effect” levels, with estradiol at a concentration that was 1% of the maximum 
response when tested individually. The experiment showed that the mixture more than 
doubled the effect of the estradiol. Some of the compounds had potencies that were 400,000 
times lower than estradiol. A previous study by Silva et al. (2002) showed that when weak 
xenoestrogens were combined at concentrations below their individual “no effect” levels, in 
the absence of estradiol, the mixture of compounds was able to produce a response in the 
YES assay. This reveals that the potency of weak xenoestrogens cannot be ignored because 
many of these compounds exist as complex mixtures in the environment. In this current 
study, it appears that bromine-containing DBPs are estrogen antagonists and iodine-
containing DBPs are androgen agonists. Also, the DBPs produced by chloramination in the 
absence of iodide are also estrogen antagonists and those produced by chlorination in the 
absence of bromide are androgen agonists.  The consumption of drinking water in which 
many of these DBPs are found may lead to agonistic and antagonistic effects on natural 
hormones such as estradiol and testosterone. Further evaluation would be needed to confirm 
such results.  
Current DBP regulations ignore iodine-containing products produced during 
chloramination of waters containing iodide. One of the major findings in this study suggests 
that such treatment might generate DBPs that have an agonistic effect on the androgenicity of 
endocrine-active compounds. 
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TABLES 
 
Table 1. The U.S. EPA Drinking Water Standards, 2012 
Disinfection Byproduct MCLG* MCL* 
Total Trihalomethanes   
Bromodichloromethane Zero 0.080 mg/L or 80 ppb 
(Sum of the 
concentrations of all 
four trihalomethanes) 
as a running annual 
average 
 
Bromoform Zero 
Dibromochloromethane 0.06 mg/L or 60 ppb 
Chloroform 0.07 mg/L or 70 ppb 
Haloacetic acids   
Dichloroacetic acid Zero 0.060 mg/L or 60 ppb 
(Sum of the 
concentrations of all 
five haloacetic acids) 
as a running annual 
average 
Trichloroacetic acid 0.02 mg/L or 20 ppb 
Monochloroacetic acid 0.03 mg/L or 30 ppb 
Bromoacetic acid Regulated with this group but has 
no MCLG 
Dibromoacetic acid Regulated with this group but has 
no MCLG 
Bromate Zero 0.010 mg/L or 10 ppb 
As a running annual 
average 
 
Chlorite 0.80 mg/L or 800 ppb 1.0 mg/L or 1 ppm 
    *Maximum Contaminant Level Goal – the maximum level of a contaminant in drinking     
      water at which no known adverse health effects occur. 
    *Maximum Contaminant Level – the maximum level of a contaminant that is allowed in  
      water which is delivered in the public water supply 
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     Table 2. OD600 nm values for the DBP compounds at the highest concentrations tested  
 in the YES assay compared to the OD600  nm of the negative control. Any significant  
 decrease in yeast cell density can be considered as cytotoxicity. N/A means that no  
 cytotoxicity occurred at these concentrations. 
Compound Highest 
conc. tested 
(M) 
Average 
OD600 nm 
Neg Control 
Average       
OD600 nm 
Cytotoxicity 
(%) 
Dichloroacetonitrile 2.16E-04 0.227 0.202 N/A 
Bromodichloromethane 7.71E-05 0.433 0.409 N/A 
Dibromoacetic acid 4.95E-04 0.658 0.391 N/A 
3-bromopropionitrile 9.44E-05 0.328 0.313 N/A 
2-bromoacetamide 9.17E-05 0.117 0.356 67 
     
 
    Table 3. OD620 nm values for the DBP compounds at the highest concentrations tested  
    in the YAS assay compared to the OD620  nm of the negative control. Any significant  
    decrease in yeast cell density can be considered as cytotoxicity. N/A means that no  
    cytotoxicity occurred at these concentrations. 
Compound Highest 
conc. tested 
(M) 
Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
Dichloroacetonitrile 4.55E-04 0.572 0.807 29 
Bromodichloromethane 3.05E-04 0.703 0.792 N/A 
Dibromoacetic acid 2.30E-04 0.778 0.791 N/A 
3-bromopropionitrile 3.74E-04 0.674 0.792 N/A 
2-bromoacetamide 3.63E-04 
1.82E-04 
9.08E-05 
4.54E-05 
0.306 
0.327 
0.359 
0.426 
0.791 61 
59 
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          Table 4. OD600 nm values for the EPA standard mix at the highest concentrations tested  
    in the YES assay compared to the OD600 nm of the negative control. Any significant  
    decrease in yeast cell density can be considered as cytotoxicity.  
Sample Highest 
conc. tested 
(M) 
Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
EPA mix (solution 1) 1.19E-03 
5.96E-04 
0.113 
0.097 
0.324 65 
70 
EPA mix (solution 2) 5.98E-04 0.225 0.605 63 
EPA mix (solution 3) 1.19E-04 0.243 0.606 60 
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    Table 5. OD620 nm values for the EPA standard mix at the highest concentrations  
          tested in the YAS assay were compared to the OD620 nm of the negative control. Any  
          significant decrease in yeast cell density can be considered as cytotoxicity. N/A means   
          that no cytotoxicity occurred at these concentrations. 
Sample Highest 
conc. tested 
(M) 
Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
EPA mix (solution 1) 1.19E-03 0.345 0.879 61 
EPA mix (solution 2) 3.97E-04 0.761 0.898 N/A 
 
 
    Table 6. EC50 values for YES dose response curves of 4-nonylphenol in 10%  
    EtOH/acetone and in 10% EtOH/EPA mix 
Sample EC50(M) 
10% EtOH/acetone 1.07E-06 
10% EtOH/EPA mix 2.42E-06  
     
         
    Table 7. EC50 values for YAS dose response curves of 4-nonylphenol in LGW/acetone  
    (control), in EPA mix (75 mg/L), in EPA mix (25 mg/L) and in LGW  
Sample EC50 (M) 
LGW/acetone  8.28E-05 
EPA mix (75 mg/L) 2.94E-04 
EPA mix (25 mg/L) 9.25E-05 
LGW 7.65E-05 
 
 
    Table 8. EC50 values for YES dose response curves of 4-nonylphenol in 10% EtOH  
    and in 10% EtOH/RO concentrates 
Sample EC50 (M) 
10% EtOH 1.62E-05 
10%EtOH/RO concentrate (121 mg/L C) 1.36E-05 
10% EtOH/RO concentrate (50 mg/L C) 1.94E-05 
10% EtOH/Settled RO concentrate (26 mg/L) 1.90E-05 
 
 
    Table 9. EC50 values for YAS dose response curves of 4-nonylphenol in LGW and in  
    RO concentrates 
Sample EC50 (M) 
LGW 6.12E-05 
RO concentrate (121 mg/L C) 7.59E-05 
RO concentrate (50 mg/L C) 9.77E-05 
Settled RO concentrate (26 mg/L) 5.97E-05 
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    Table 10. OD600 nm  values for the RO waters tested in the YES assay compared to the   
    OD600 nm of 10% ethanol. Any significant decrease in yeast cell density can be  
    considered as cytotoxicity. N/A means that no cytotoxicity occurred at these  
    concentrations. 
Sample Highest TOC 
tested (mg/L C) 
Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
RO concentrate 121 0.295 0.385 N/A 
Diluted RO concentrate 50 0.434 0.285 N/A 
Settled RO concentrate 26 0.295 0.295 N/A 
     
 
    Table 11. OD620 nm  values for the RO waters tested in the YAS assay compared to the   
    OD620 nm of LGW. Any significant decrease in yeast cell density can be considered as  
    cytotoxicity. N/A means that no cytotoxicity occurred at these concentrations. 
Sample Highest 
TOC tested 
(mg/L C) 
Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
RO concentrate 121 0.880 0.813 N/A 
Diluted RO concentrate 50 0.892 0.813 N/A 
Settled RO concentrate 26 0.903 0.813 N/A 
 
 
    Table 12. The corrected absorbance values at 450 nm for the RO waters tested in  
    the YES assay compared to the highest value of the nonylphenol positive control.  
Sample Highest 
TOC conc.  
(mg/L C) 
Average 
Corrected 
Absorbance 
Positive 
Control 
Average       
RO concentrate 121 -0.006 0.104 
Diluted RO concentrate 50 -0.079 0.104 
Settled RO concentrate 26 -0.009 0.104 
     
 
    Table 13. The corrected absorbance values at 540 nm for the RO waters tested in  
    the YAS assay compared to the highest value of the nonylphenol positive control.      
Sample Highest 
TOC conc.  
(mg/L C) 
Average  
Corrected 
Absorbance 
Positive 
Control 
Average       
RO concentrate 121 1.058 3.203 
Diluted RO concentrate 50 1.005 3.203 
Settled RO concentrate 26 1.094 3.203 
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    Table 14. EC50 values for YES dose response curves of 4-nonylphenol in 10% EtOH  
    and in 10% EtOH/residuals 
Sample EC50 (M) 
10% EtOH 3.32E-05 
10% EtOH/NaOCl  3.44E-05 
10% EtOH/NH2Cl 3.14E-05 
 
 
    Table 15. EC50 values for YAS dose response curves of 4-nonylphenol in LGW and in  
    residuals 
Sample EC50 (M) 
LGW 6.47E-05 
NaOCl (5 mg/L as Cl2) 6.55E-05 
NaOCl (2 mg/L as Cl2) 7.78E-05 
NH2Cl (5 mg/L as Cl2) 7.98E-05 
NH2Cl (2 mg/L as Cl2) 7.85E-05 
 
 
    Table 16. OD600 nm  values for the chlorine and chloramine residuals tested in the YES  
    assay compared to the  OD600 nm of 10% ethanol. Any significant decrease in yeast cell  
    density can be considered as cytotoxicity. N/A means that no cytotoxicity occurred at  
    these concentrations. 
Sample Highest 
residual 
tested (mg/L 
as Cl2) 
Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
NaOCl  5 0.341 0.489 N/A 
NH2Cl 5 0.535 0.489 N/A 
 
 
    Table 17. OD620 nm  values for the chlorine and chloramine residuals tested in the YAS  
    assay compared to the  OD620 nm of LGW. Any significant decrease in yeast cell density  
    can be considered as cytotoxicity. N/A means that no cytotoxicity occurred at these  
    concentrations. 
Sample Highest 
residual 
tested (mg/L 
as Cl2) 
Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
NaOCl  5 0.860 0.850 N/A 
NH2Cl 5 0.864 0.850 N/A 
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    Table 18. The corrected absorbance values at 450 nm for the chlorine and chloramine  
    residuals tested in the YES assay compared to the highest value of the  
    nonylphenol positive control.  
Sample Highest 
residual 
tested (mg/L 
as Cl2) 
Average 
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl 5 -0.001 0.726 
NH2Cl 5 0.001 0.726 
    
 
    Table 19. The corrected absorbance values at 540 nm for the chlorine and chloramine  
    residuals tested in the YAS assay compared to the highest value of the  
    nonylphenol positive control.      
Sample Highest 
residual 
tested (mg/L 
as Cl2) 
Average  
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl 5 0.099 2.249 
NH2Cl 5 0.074 2.249 
 
 
    Table 20. EC50 values for YES dose response curves of 4-nonylphenol in 10% EtOH  
    and in 10% EtOH/bromide and iodide 
Sample EC50 (M) 
10% EtOH 7.88E-05 
10% EtOH/1.5 mg/L Br
- 
8.77E-05 
10% EtOH/0.5 mg/L Br
- 
1.29E-04 
10% EtOH/0.5 mg/L I
- 
4.05E-04 
 
 
    Table 21. EC50 values for YAS dose response curves of 4-nonylphenol in LGW and in  
    bromide and iodide 
Sample EC50 (M) 
LGW 1.28E-04 
1.5 mg/L Br
- 
1.18E-04 
0.5 mg/L Br
- 
1.39E-04 
0.5 mg/L I
-  
1.22E-04 
0.1 mg/L I
- 
1.21E-04 
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    Table 22. OD600 nm  values for the bromide and iodide concentrations tested in the  
    YES assay compared to the OD600 nm of 10% ethanol. Any significant decrease in yeast  
    cell density can be considered as cytotoxicity. N/A means that no cytotoxicity occurred  
    at these concentrations. 
Sample Highest 
residual 
tested 
(mg/L) 
Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
Bromide 1.5 0.376 0.350 N/A 
Iodide 0.5 0.289 0.350 N/A 
 
 
    Table 23. OD620 nm  values for the bromide and iodide concentrations tested in the  
    YAS assay compared to the  OD620 nm of LGW. Any significant decrease in yeast cell  
    density can be considered as cytotoxicity. N/A means that no cytotoxicity occurred at  
    these concentrations. 
Sample Highest 
residual 
tested (mg/L 
as Cl2) 
Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
Bromide  1.5 0.887 0.874 N/A 
Iodide 0.5 0.945 0.874 N/A 
 
 
    Table 24. The corrected absorbance values at 450 nm for the bromide and iodide  
    concentrations tested in the YES assay compared to the highest value of the  
    nonylphenol positive control.  
Sample Highest ion 
conc. tested 
(mg/L) 
Average 
Corrected 
Absorbance 
Positive 
Control 
Average       
Bromide 1.5 -0.011 0.154 
Iodide 0.5 -0.003 0.154 
 
 
    Table 25. The corrected absorbance values at 540 nm for the bromide and iodide  
    concentrations tested in the YAS assay were compared to the highest value of the  
    nonylphenol positive control.      
Sample Highest ion 
conc. tested 
(mg/L) 
Average  
Corrected 
Absorbance 
Positive 
Control 
Average       
Bromide 1.5 -0.055 2.189 
Iodide 0.5 0.007 2.189 
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    Table 26. The doses of chlorine used, as Cl2, and the residuals measured 2 weeks after  
    disinfection. 
NaOCl dose as Cl2 (mg/L) Free Cl2 residual (mg/L) 
20 0.04 
25 0.04 
35 0.04 
45 0.03 
 
 
    Table 27. The doses of chloramine used, as Cl2, and the residuals measured 2 weeks  
    after disinfection. 
NH2Cl dose as Cl2 
(mg/L) 
Free Cl2 residual 
(mg/L) 
Chloramine residual 
(mg/L) 
2 0.07 0.00 
5 0.04 0.09 
8 0.04 0.44 
12 0.05 1.11 
 
 
    Table 28. EC50 values for YES dose response curves of 4-nonylphenol in LGW and in  
    the disinfected waters after two weeks reaction time 
Sample EC50 (M) 
LGW 4.02E-05 
NaOCl treated water 8.66E-05 
NH2Cl treated water (12 mg/L as Cl2 dose) 9.57E-05 
NH2Cl treated water (2 mg/L as Cl2 dose) 3.14E-04 
 
 
          Table 29. OD600 nm  values for the disinfected waters tested in the YES  
    assay were compared to the  OD600 nm of LGW. Any significant decrease in yeast cell  
    density can be considered as cytotoxicity. N/A means that no cytotoxicity occurred at  
    these concentrations. 
Sample Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
NaOCl treated water 0.355 0.392 N/A 
NH2Cl treated water    
(12 mg/L as Cl2 dose) 
0.433 0.392 N/A 
NH2Cl treated water     
(2 mg/L as Cl2 dose) 
0.436 0.392 N/A 
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          Table 30. The corrected absorbance values at 450 nm for the disinfected waters tested  
          in the YES assay compared to the highest value of the nonylphenol positive control. 
Sample Average 
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl treated water 0.043 0.121 
NH2Cl treated water    
(12 mg/L as Cl2 dose) 
0.042 0.121 
NH2Cl treated water     
(2 mg/L as Cl2 dose) 
0.044 0.121 
    
 
    Table 31. The doses of chlorine used, as Cl2, and the residuals measured 6 weeks after  
    disinfection. 
NaOCl dose as Cl2 (mg/L) Free Cl2 residual (mg/L) 
45 0.00 
55 0.01 
     
 
    Table 32. The doses of chloramine used, as Cl2, and the residuals measured 6 weeks  
    after disinfection. 
NH2Cl dose as Cl2 
(mg/L) 
Free Cl2 residual 
(mg/L) 
Chloramine residual 
(mg/L) 
2 0.05 0.24 
12 0.17 0.11 
 
 
    Table 33. EC50 values for YES dose response curves of 4-nonylphenol in 10% EtOH  
    and in 10% EtOH/disinfected waters after 6 weeks reaction time 
Sample EC50 (M) 
10% EtOH 3.15E-05 
10% EtOH/NaOCl treated water 3.97E-05 
10% EtOH/NH2Cl treated water (12 mg/L as Cl2 dose) 2.39E-05 
10% EtOH/NH2Cl treated water (2 mg/L as Cl2 dose) 2.78E-05 
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    Table 34. OD600 nm  values for the disinfected waters tested in the YES  
    assay were compared to the  OD600 nm of 10% ethanol. Any significant decrease in  
    yeast cell density can be considered as cytotoxicity. N/A means that no cytotoxicity  
    occurred at these concentrations. 
Sample Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
NaOCl treated water 0.363 0.489 N/A 
NH2Cl treated water    
(12 mg/L as Cl2 dose) 
0.488 0.489 N/A 
NH2Cl treated water     
(2 mg/L as Cl2 dose) 
0.385 0.489 N/A 
 
 
    Table 35. The corrected absorbance values at 450 nm for the disinfected waters tested  
     in the YES assay compared to the highest value of the nonylphenol positive control.  
Sample Average 
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl treated water 0.000 0.726 
NH2Cl treated water    
(12 mg/L as Cl2 dose) 
0.002 0.726 
NH2Cl treated water     
(2 mg/L as Cl2 dose) 
0.027 0.726 
 
 
    Table 36. EC50 values for YAS dose response curves of 4-nonylphenol in LGW and in  
    the disinfected waters after 6 weeks reaction time 
Sample EC50 (M) 
LGW 8.68E-05 
NaOCl treated water 4.84E-05 
NH2Cl treated water (12 mg/L as Cl2 dose) 9.65E-05 
NH2Cl treated water (2 mg/L as Cl2 dose) 9.54E-05 
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          Table 37. OD620 nm  values for the disinfected waters tested in the YAS  
    assay compared to the  OD620 nm of LGW. Any significant decrease in  
    yeast cell density can be considered as cytotoxicity. N/A means that no   
          cytotoxicity occurred at these concentrations. 
Sample Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
NaOCl treated water 0.857 0.818 N/A 
NH2Cl treated water    
(12 mg/L as Cl2 dose) 
0.865 0.818 N/A 
NH2Cl treated water     
(2 mg/L as Cl2 dose) 
0.867 0.818 N/A 
 
 
    Table 38. The corrected absorbance values at 540 nm for the disinfected waters tested  
     in the YAS assay were compared to the highest value of the nonylphenol positive  
    control.  
Sample Average  
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl treated water 1.274 3.202 
NH2Cl treated water    
(12 mg/L as Cl2 dose) 
1.111 3.202 
NH2Cl treated water     
(2 mg/L as Cl2 dose) 
0.036 3.202 
 
 
    Table 39. The doses of chlorine and chloramine used, as Cl2, and the residuals  
    measured approximately two weeks after disinfection. These doses were added to the  
    spiked RO concentrate. 
Disinfectant dose (mg/L) Free Cl2 residual 
(mg/L) 
Chloramine residual 
(mg/L) 
NaOCl (58) 0.04 N/A 
NH2Cl (12) 0.08 0.82 
   
 
    Table 40. EC50 values for YES dose response curves of 4-nonylphenol in 10% EtOH  
    and in 10%EtOH/disinfected spiked RO concentrate after two weeks reaction time 
Sample EC50 (M) 
10% EtOH 4.44E-05 
10% EtOH/NaOCl treated water (Br
-
 spiked) 8.15E-05 
10% EtOH/NH2Cl treated water (I
-
 spiked) 4.95E-05 
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    Table 41. EC50 values for YAS dose response curves of 4-nonylphenol in LGW and in  
    the disinfected spiked RO concentrate after two weeks reaction time 
Sample EC50 (M) 
LGW 2.25E-04 
NaOCl treated water (Br
-
 spiked) 1.74E-04 
NH2Cl treated water (I
-
 spiked) 8.75E-05 
 
 
          Table 42. OD600 nm  values for the disinfected spiked waters tested in the YES  
    assay were compared to the  OD600 nm of 10% ethanol. Any significant decrease in  
    yeast cell density can be considered as cytotoxicity.N/A means that no cytotoxicity  
    occurred at these concentrations. 
Sample Average 
OD600 nm 
Neg Control 
Average      
OD600 nm 
Cytotoxicity 
(%) 
NaOCl treated water 
(Br
-
 spiked) 
0.373 0.358 N/A 
NH2Cl treated water    
(I
-
 spiked) 
0.578 0.358 N/A 
 
 
    Table 43. OD620 nm  values for the disinfected spiked waters tested in the YAS  
    assay OD620 nm  were compared to the  OD620 nm of LGW. Any significant decrease in  
    yeast cell density can be considered as cytotoxicity. N/A means that no cytotoxicity  
    occurred at these concentrations. 
Sample Average 
OD620 nm 
Neg Control 
Average      
OD620 nm 
Cytotoxicity 
(%) 
NaOCl treated water 
(Br
-
 spiked) 
0.823 0.815 N/A 
NH2Cl treated water  
(I
-
 spiked)    
0.960 0.815 N/A 
         
 
          Table 44. The corrected absorbance values at 450 nm for the disinfected spiked waters  
    tested in the YES assay compared to the highest value of the nonylphenol positive  
    control.  
Sample Average 
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl treated water 
(Br
-
 spiked) 
0.016 0.543 
NH2Cl treated water   
(I
-
 spiked) 
-0.004 0.543 
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    Table 45. The corrected absorbance values at 540 nm for the disinfected spiked waters  
    tested in the YAS assay were compared to the highest value of the nonylphenol  
    positive control.  
Sample Average  
Corrected 
Absorbance 
Positive 
Control 
Average       
NaOCl treated water 
(Br
-
 spiked) 
0.076 1.911 
NH2Cl treated water   
(I
-
 spiked) 
1.185 1.911 
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FIGURES 
 
In each of the figures, 4-nonylphenol is referred to as 4-NP. 
 
 
 
       
 
 
  Figure 1. The Drinking Water Treatment Process.  
Source: AWWA Drinking Water Week Blue Thumb Kit. Available 
online at  
http://www.excelwater.com/eng/img_site/about_water/treatment_3.jpg 
 
                                       
         
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 2. YES dose response curve for serial dilutions of                  
  4-nonylphenol (1.13E-04 M to 1.11E-07 M) in 10% ethanol           
  (EC50 = 3.17E-05 M). The absorbance of the yeast dilution was  
  0.086 absorbance units. Only one absorbance value was plotted at   
  4.24E-07 M  
     
 
 
       
 
 
 
 
 
 
 
 
 
 
 
  Figure 3. YES dose response curve for serial dilutions of                     
  4-nonylphenol (1.13E-04 M to 1.11E-07 M) in 10% ethanol            
  (EC50 = 3.14E-01 M). The absorbance of the yeast dilution was  
  0.222 absorbance units. 
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 Figure 4.  YES dose response curve for serial dilutions of                   
 4-nonylphenol (5.90E-05 M to 5.76E-08 M) in 10% ethanol             
 (EC50 = 2.78E-06 M). This was the positive control for Figures 19 &  
 20. 
 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. YAS dose response curve for serial dilutions of                 
4-nonylphenol (2.27E-04 M to 2.22E-07 M) in ethanol                  
(EC50 = 2.22E-04 M). The absorbance of the yeast dilution was 0.114 
absorbance units. An outlier was omitted from the data at 
concentration 3.33E-06 M. 
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      Figure 6. YAS dose response curve for serial dilutions of              
      4-nonylphenol (2.27E-04 M to 2.22E-07 M) in ethanol                
      (EC50 = 2.67 E-04 M). The absorbance of the yeast  
      dilution was 0.274 absorbance units.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 7. YES dose response curve for serial dilutions of estradiol  
  (1.25E-08 M to 1.22E-11 M) in 10% ethanol (EC50 = 1.55E-10 M).   
  This was the positive control used in the individual DBP  
  experiment. 
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Figure 8. YES dose response curve for serial dilutions of                 
2-bromoacetamide (9.17E-05 M to 8.95E-08 M) in 10% ethanol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. YES dose response curve for serial dilutions of 
dichloroacetonitrile (2.16E-04 M to 2.11E-07 M) in 10% ethanol. 
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 Figure 10. YES dose response curve for serial dilutions of    
 dibromoacetic acid (4.96E-04 M to 4.84E-07 M) in 10% ethanol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 11. YES dose response curve for serial dilutions of               
  3-bromopropionitrile (9.44E-05 M to 9.22E-08 M) in 10% ethanol.  
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  Figure 12. YES dose response curve for serial dilutions of   
  bromodichloromethane (7.71E-05 M to 7.53E-08 M) in 10%  
  ethanol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 13. YAS dose response curve for serial dilutions of              
 4-nonylphenol (1.65E-03 M to 1.61E-06 M) in 12 % ethanol         
 (EC50  = 1.66E-05 M). This was used as the positive control for  
 Figures 14-18. 
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        Figure 14. YAS dose response curve for serial dilutions of   
                                         dichloroacetonitrile (3.03E-03 M to 2.96E-06 M) in 12 % ethanol. 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
    Figure 15. YAS dose response curve for serial dilutions of   
    dibromoacetic acid (1.53E-03 M to 1.50E-06 M) in 12% ethanol. 
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 Figure 16. YAS dose response curve for serial dilutions of               
 2- bromoacetamide (2.42E-03 M to 2.36E-06 M) in 12% ethanol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 17. YAS dose response curve for serial dilutions of              
 3-bromopropionitrile (2.49E-03 M to 2.44E-06 M) in 12% ethanol.
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Figure 18. YAS dose response curve for serial dilutions of 
bromodichloromethane (2.03E-03 M to 1.99E-06 M) in 12% 
ethanol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. YES dose response curve for serial dilutions of the EPA 
standard mix (1.19E-03 M to 1.16E-06 M of each component) in 
10% ethanol.  
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 Figure 20. YES dose response curve for serial dilutions of the EPA  
 standard mix (1.19E-04 M to 1.16E-07 M of each component) in   
 10% ethanol. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 21. YAS dose response curve for serial dilutions of 4- 
     nonylphenol (2.27E-04 M to 2.22E-07 M) in ethanol. This was the  
     positive control for Figures 22 & 23. 
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  Figure 22. YAS dose response curve for serial dilutions of the  
  EPA standard mix (1.19E-03 M to 1.17E-06 M of each   
  component) in LGW 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Figure 23. YAS dose response curve for serial dilutions of the    
     EPA standard mix (3.97E-04 M to 3.87E-07 M of each component)  
     in LGW 
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        Figure 24. YES dose response curves for serial dilutions of 4-nonylphenol   
        (6.24E-05 M to 6.09E-08 M) in 10% ethanol/acetone and in 10% ethanol with the EPA  
        standard mix spiked in to achieve a concentration of 10 mg/L or 4.76E-04 M of each  
        component. 4-nonylphenol was diluted across the wells in the EPA standard mix  
        (4.76E-04 M)  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
        Figure 25. YAS dose response curves for serial dilutions of 4-nonylphenol             
        (2.27E-04 M to 2.22E-07 M) in LGW, in EPA standard mix at 75 mg/L or 3.57E-03 M  
        of each component, in EPA standard mix at 25 mg/L or 1.19E-03 M of each component  
        and in LGW/acetone. 4-nonylphenol was diluted across the wells in the EPA standard  
        mix. An outlier was omitted for EtOH/LGW/acetone at 2.22E-07 M 
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  Figure 26. Effects of RO concentrates on dose response of 4-nonylphenol              
  (6.78E-05 M to 6.63E-08 M) by YES, in 10% ethanol and in RO concentrates.               
  4-nonylphenol was diluted across the wells in the RO concentrate solutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 27. Effects of RO concentrates on dose response of 4-nonylphenol               
 (2.27E-04 M to 2.22E-07 M) by YAS. 4-nonylphenol was diluted across the  
 plate in ethanol and the RO concentrate solutions were added after evaporation of the  
 ethanol.  
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 Figure 28. Effects of chlorine and monochloramine residuals on dose response of          
 4-nonylphenol (6.24E-05 M to 6.09E-08 M) by YES. 4-nonylphenol was diluted across  
 the wells in 10% ethanol and the chlorine solutions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 29. Effects of chlorine and monochloramine residuals on dose response of         
        4-nonylphenol (2.27E-04 M to 2.22E-07 M) by YAS. 4-nonylphenol was diluted across  
        the wells in ethanol and the LGW, chlorine and chloramine solutions added after  
        evaporation of the ethanol.  
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   Figure 30. Effects of bromide and iodide on dose response of 4-nonylphenol         
   (1.23E-04 M to 1.21E-07 M) by YES. 4-nonylphenol was diluted across the wells in  
   10% ethanol, and the bromide and iodide solutions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
             Figure 31. Effects of bromide and iodide on dose response of 4-nonylphenol    
             (2.27E-04 M to 2.22E-07 M) by YAS. 4-nonylphenol was diluted across the plate in  
             ethanol and the LGW, and bromide and iodide solutions added after evaporation of  
             ethanol.  
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             Figure 32. Effects of treated RO concentrates on dose response of 4-nonylphenol  
             (1.07E-04 M to 1.04E-07 M) by YES. 4-nonylphenol was diluted across the wells in  
             the treated waters. The positive control in this experiment was the LGW because the  
             other samples were not prepared in 10% ethanol.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            Figure 33. Effects of treated RO concentrates on dose response of 4-nonylphenol  
            (6.24E-05 M to 6.09E-08 M) by YES. 4-nonylphenol was diluted across the wells in    
            the treated waters. These samples were run 6 weeks after the waters were  
            treated with the disinfectants.  
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          Figure 34. Effects of treated RO concentrates on dose response of 4-nonylphenol  
          (2.27E-04 M to 2.22E-07 M) by YAS. 4-nonylphenol was diluted across the wells in  
          ethanol and the treated waters added after evaporation. These samples were run 6  
          weeks after the waters were treated with the disinfectants. An outlier was omitted from  
          the LGW data at 5.68E-05 M.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Figure 35. Effects of treated spiked RO concentrates on dose response of 4-nonylphenol  
        (6.24E-05 M to 6.09E-08 M) by YES. 4-nonylphenol was diluted across the wells in the  
        treated waters.  
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         Figure 36. Effects of treated spiked RO concentrated on dose response of                     
         4-nonylphenol (2.27E-04 M to 2.22E-07 M) by YAS. 4-nonylphenol was  
         diluted across the wells in ethanol and the treated waters added after evaporation of  
         ethanol.  
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APPENDIX A: Yeast Estrogen Screen (YES) Assay Protocol 
 
The method and solution preparation were originally prepared by Paul Ebohon. The 
procedure is modified from the work of Routledge and Sumpter (1996) and Chen et al., 
(2007). The yeast strain (Saccharomyces cerevisiae) used for this assay was provided under 
agreement with Professor J.P Sumpter at Brunel University, UK. This protocol was written 
by Paul Ebohon at the University of North Carolina at Chapel Hill on January 4, 2011 and 
modified on July 9, 2011. 
 
Part 1: Materials needed 
 
96 well plate reader* (Molecular Devices, EMAX; Sunnyvale, California) 
Centrifuge* (International Equipment Company; Needham Heights, Massachusetts) 
Shaker table** (Barnstead International; Dubuque, Iowa) 
Incubator** (Fisher Scientific; Dubuque Iowa) 
Weighing scale (Sartorius; Goettingen, Germany) 
Stirrer (Barnstead/Thermolyne; Dubuque, Iowa) 
Disposable filter sterilization flasks (Corning Incorporated; Corning, New York) 
Disposable (100 x 15 mm) sterile petri dishes (Fisher Scientific; Suwanee, Georgia) 
Disposable 96 well flat bottom microplates (Greiner-Bio-One; Frickenhausen, Germany) 
Disposable 96 deep well 1 mL plates (Fisher Scientific; Suwanee, Georgia) 
Falcon tube (Becton Dickinson Labware, Franklin Lakes, New Jersey) 
Plate Sealing Film (Denville Scientific; Metuchen, New Jersey) 
Disposable V-shaped wells for multichannel pipetting (USA Scientific; Ocala, Florida) 
Vortex mixer (Barnstead/Thermolyne; Dubuque, Iowa) 
Original potable pipette aid (Drummond Scientific; Broomall, Pennsylvania) 
50 – 300 µL 8 multichannel  pipettor: 50 – 300 µL (Thermo Labsystems; Vantaa, Finland) 
100 – 1000 µL pipettor (Fisher Scientific; Dubuque, Iowa) 
Disposable (1 – 250 µL)  pipette tips  (Fisher Scientific; Suwanee, Georgia) 
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20 -100 µL pipettor (Pipetman; Middleton, Wisconsin) 
Weighing paper: 152 x 152 mm (Fisherbrand; Suwanee, Georgia) 
1L reusable media/solution glass bottles (Corning Incorporated; Corning, New York) 
250 mL screw cap Erlenmeyer glass flask (Kimble Chase Kontes; Vineland, New Jersey) 
1, 5, 10 and 25 mL plastic disposable pipettes (Fisher Scientific; Raleigh, North Carolina) 
 
*Located in room *2104 and **1213 
 
Part 2: Chemicals Needed 
Chemical    CAS #   Brand/Source used by Weinberg lab 
Difco yeast nitrogen base 2014-11-30  BD; Sparks, MD 
Ammonium sulfate  7783-20-2  Mallinckrodt; Paris, KY 
Adenine sulfate  321-30-2  Acros Organics; New Jersey, NJ 
Casamino acids  65072-00-6  Fisher Scientific; Fair Lawn, NJ 
Dextrose anhydrous  50-99-7  Fisher Scientific; Fair Lawn, NJ 
Bacto agar   2014-03-31  BD; Sparks, MD 
Bacto peptone   2012-04-22  BD; Sparks, MD 
Sucrose   57-50-1  Fisher Scientific; Fair Lawn, NJ 
a
Na2HPO4 * 7H2O  7782-85-6  Mallinckrodt; Paris, KY 
b
NaH2PO4 * H2O  10049-21-5  Mallinckrodt; Paris, KY 
Potassium chloride  7447-40-7  Fisher Scientific; Fair Lawn, NJ 
c
MgSO4 * 7H2O  10034-99-8  Acros Organics; New Jersey, NJ 
2-mercaptoethanol (βME) 60-24-2  Acros Organics; New Jersey, NJ 
20% Sodium dodecyl sulfate 151-21-3  Fisher Scientific; Fair Lawn, NJ 
d
CuSO4 * 5H2O  7758-99-8  EM Science; Gibbstown, NJ 
e
o-NPG   369-07-3  Research Organics; Cleveland, OH 
Sodium carbonate  497-19-8  Mallinckrodt; Paris, KY  
a
Na2HPO4 * 7H2O: Sodium hydrogen phosphate heptahydrate 
b
NaH2PO4 * H2O: Sodium dihydrogen phosphate monohydrate  
c
MgSO4 * 7H2O: Magnesium sulfate septahydrate 
d
CuSO4 * 5H2O: Cupric sulfate pentahydrate 
e
o-NPG: o-Nitrophenyl-β-D-galactopyranoside 
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Part 3: Preparation of solutions and buffers 
Solutions should be made in sterilized bottles or vials with laboratory grade water (LGW) 
and stored at room temperature unless otherwise stated in this SOP. Any solution should be 
discarded in the event of a visible color change or visible turbidity 
 
 
Liquid URA-TRP media for yeast cells growth (500 mL): 
- 3.35 g Yeast Nitrogen Base without amino acids and ammonium sulfate 
- 2.5 g ammonium sulfate 
- 2.5 mL adenine sulfate (4 mg/mL) 
- 10 g anhydrous dextrose 
- 2.5 g casamino acids 
- Dissolve in 500 mL LGW  
- Filter sterilize using a disposable filter sterilization flask and transfer into an autoclaved 
1Lscrew top glass bottle before storing at room temperature. 
 
 
URA-TRP Solid media for yeast cell propagation (500 mL): 
- Add 10 g of bactoagar to 500 mL liquid Ura-Trp media 
 
- Autoclave using the liquid cycle and limit sterilization time to 15 minutes because a 
longer one will degrade dextrose in the media. 
 
- Place autoclaved container under hood and allow cooling until it can be handled without 
difficulty. Do not shake the content of the autoclaved bottle at this point because this 
would cause bubbles to be present in the media.  
 
- Pour 15-20 mL of media into disposable sterile petri dishes. 
- Let stand at room temperature to harden 
- Place petri plates in dated ziploc bags and store at 4C. 
 
YPS Media used to make the diluted yeast solution (500 mL): 
- 5 g Yeast Nitrogen Base without amino acids and ammonium sulfate 
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- 2.5 g peptone 
- 50 g sucrose 
- Filter sterilize using a disposable filter sterilization flask and transfer into an autoclaved  
1 L screw top glass bottle before storing at room temperature. 
 
 
Z-Buffer solution (1L): 
- 16.1 g disodium hydrogen phosphate heptahydrate (60 mM final) 
- 5.5 g sodium dihydrogen phosphate monohydrate (40 mM final) 
- 0.75 g  potassium chloride (10 mM final) 
- 0.246 g magnesium sulfate heptahydrate (1 mM final) 
- Adjust pH to 7.0 by using a 2 M potassium hydroxide solution 
- Filter sterilize using a disposable filter sterilization flask and store at room temperature. 
Immediately before using, add 135 μL of β-mercaptoethanol (βME) per 50 mL of Z-
buffer solution .βME cannot be added in advance because it becomes oxidized and loses 
its potency over time. 
 
10% Sodium dodecyl sulfate (SDS) used to denature proteins prior to colorimetric 
measurement: 
 
Note: Make in small batches because it will lose its potency after a month 
- Transfer 5 mL LGW into a 250 mL screw top bottle 
- Transfer 5mL 20% SDS into the bottle containing LGW and swirl contents 
- Label bottle as 10% SDS  and include intials , date and time of preparation 
 
1M sodium carbontate solution (500 mL) that stops the reaction of β-galactosidase with       
o-NPG by shifting the reaction mixture to pH 11: 
 
- Dissolve 59.5 g sodium carbonate in enough water to make 500 mL. 
 
- Filter sterilize using a disposable filter sterilization flask and store at room temperature 
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Copper (II) sulfate solution (250 mL): 
- Dissolve 0.122g CuSO4 * 5H20 in enough water to make 250 mL. 
 
- Filter sterilize using a disposable filter sterilization flask and store at room temperature. 
 
 
10% Ethanol (EtOH) used for serial dilution of the samples and the 4-nonylphenol standard:. 
NOTE:  In order to avoid possible volatilization of the EtOH from LGW, make this solution  
right before performing the assay. 
 
- Dissolve 1 mL ethanol in 9 mL of LGW. 
 
17-β-estradiol (E2) stock solutions (in 100% ethanol): 
- 1E-2M E2 stock: dissolve 27.38 mg E2 in a 10 mL volumetric flask with ethanol 
- 1E-4M E2: add 100 µL of 1E-2M E2 stock solution to a 10 mL volumetric flask with 
ethanol 
 
- 1E-6M E2: add 100 µL of 1E-4M E2 stock solution to a 10 mL volumetric flask with 
ethanol 
 
- All stock solutions should be stored at -20°C 
 
5E-8M E2 working solution (in 10% ethanol): 
- Add 9 mL LGW to an amber vial 
- Add 1 mL ethanol and 1 mL 1E-6M E2 stock solution to the vial 
- Add an additional 9 mL LGW to the vial. Mix the contents well. 
- Store at 4°C 
NOTE: This E2 working standard solution can be used for at least two weeks; however, it is 
recommended to make it fresh before each assay.  
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Part 4: Yeast Cell Propagation and Assay Procedure: 
1. Yeast cell propagation 
I. Cell growth on solid Ura-Trp media: A petri dish containing viable yeast colonies 
was provided by  North Carolina State University and this dish was subsequently 
used for streaking the next yeast generations. 
 
1) Using a sterile wand, streak a single colony of yeast from a previous plate onto an 
Ura-Trp solid media plate. Seal the plate with parafilm and incubate at 30C. 
After 60 - 72 hours (when individual colonies have reached 1-2 mm in diameter), 
the plates should be removed from the incubator and stored at 4C. 
 
NOTE: Plates containing yeast colonies can be stored at 4C for 2 months; however, 
it is a good practice to streak fresh plates at least every month in order to keep the 
yeast colonies going. 
 
 
2.   Assay Procedure 
 
NOTE:  Slightly different procedures must be followed depending on whether samples  
are prepared in 10 or 100% ethanol and other solvents.  See details below based on  
what solvents your samples are prepared in. 
 
 
DAY 1 
II. NOTE: If your samples are prepared in 100% EtOH, you will need to prepare your 96 
well plates today in order to allow the solvent to evaporate overnight. This assay        
procedure assumes duplicate analysis for each sample with nonylphenol being used    
as positive control, and 10% ethanol or suitable matirx as a negative control on every 
plate. A separate plate containing the samples, nonylphenol and negative control       
should also be assayed simultaneously with the assay media containing no yeast cells 
in order to determine if   the samples reacts with o-NPG; thereby, generating false    
positive results. When analyzing Disinfection By-Products (DBPs), do not use this     
step because they do not evaporate completely after 24 hours.  
 
1) Add 200 µL of 5E-8M E2 standard (in 100% EtOH) to the first column of rows A 
and B   (See Figure A.1). 
 
2) Add 200 µL of sample (in 100% EtOH) in duplicate to row C-H.  A total of 3       
samples can be run on each plate (See Figure A.1). 
 
3) Place the plates in the fume hood for 24 hours to completely evaporate solvent in   
the wells.  
 
NOTE: Cover plates loosely with Kim wipes to prevent dust from falling in. 
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III. Grow yeast cells in liquid Ura-Trp media: 
1) Aliquot 7 mL of liquid Ura-Trp media into a 50 mL sterile falcon tube.  
 
2) Using a sterile wand, pick up one independent colony from a solid Ura-Trp plate  
and transfer it to the liquid media in the falcon tube. 
 
3) Incubate the yeast cells at 30C on a shaker table at 200 rpm for 24 hours. 
 
DAY 2 
IV. Determination of yeast cell density and its dilution using YPS media 
1) Vortex the falcon tube containing the 24 hour yeast suspension culture by using a 
vortex mixer. Ensure that the 96 well plate reader is turned on at least 10 minutes 
prior to use. 
2) Plate 100 L (in triplicate) of the yeast suspension on 96-well flat bottom            
microplate. Also plate 100 μL (in triplicate) of the YPS media on the same           
plate.  Read the plate at an absorbance of 600 nm in a plate reader. 
 
3) Calculate the total volume of yeast cell solution that is used for each set of            
experiments: 
a) Subtract Abs600YPS from Abs600Yeast 
 
b) Solve for x:  (Abs600Yeast – Abs600YPS)(x μL) = (0.07)(100 μL) 
 
c) Solve for y:  (x μL)/(100μL) = (y mL)/(33 mL) 
 
d) y mL of yeast + (33-y) mL of YPS = dilution of the yeast suspension needed    
for the assay. 
 
e) Make the yeast dilution calculated above. In order to ensure that there is         
enough yeast solution; make 33 mL of diluted yeast suspension per YES plate.  
 
f) Check your yeast dilution to make sure that the Abs600 falls in the range of     
0.06 and 0.08 (Once again, subtract Abs600YPS to account for background). 
 
g) Add 100 L of CuSO4 solution per 10 mL to the diluted yeast solution and     
vortex to mix. 
 
V. Prepare 96 deep well 1 mL plates: If your samples were prepared in 10% ethanol, 
ignore step 2 below. 
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   NOTE:If your samples and nonylphenol working standard solution were prepared    
   in 100% EtOH, you should have completed this step on Day 1 in order to allow      
   evaporation overnight.  
 
1) For samples prepared in 10 and 100% EtOH: Using a multichannel pipettor, add  
100 L of freshly prepared 10% ethanol to each well in columns 12-2 of a  96      
deep well 1 mL plate. 
 
2) For samples prepared only in 100% EtOH: Using a multichannel pipettor, add 200 
μL of 10% EtOH to each of the wells in column 1. Aspirate each well thoroughly 
with the multichannel pipettor in order to resuspend the samples in the 10% EtOH
. 
 
3) For samples prepared in 10% EtOH: Add 200 µL of 2.50E-04M nonylphenol      
working standard solution to the first column of rows A and B (Wells A1 and B1).  
Add 200 µL of samples (prepared in 10% EtOH) in duplicate to row C-H. A         
total of 3 samples can be run on each plate (See Figure A.1). 
 
4) Using a multichannel pipettor, dilute each column serially in 1:2 dilutions.            
(Transfer 100 μL of sample from column 1 to column 2; mix thoroughly by          
aspirating, then transfer 100 μL from column 2 to column 3. Continue the serial    
dilution across entire plate until you get to column 11. After mixing the contents  
of column 11, withdraw 100 u L that would be discarded as waste so that the        
column 12 wells containing the negative control  as shown in the YES assay         
template (Figure A.1) has only 10% ethanol at this point. 
 
                 
        
  
VI. Exposure of yeast cell to samples: 
1) Add 300 μL of the diluted yeast solution to each well of the 96 deep well 1 mL plate 
containing the samples, nonylphenol and negative control. Ensure that you perform 
this addition by starting from column 12 which contains the negative control. Ensure 
that each pipette has the same level of diluted yeast solution and no bubbles prior to 
placing in wells. 
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2) Cover plate with a plate sealing film and incubate for 3 days at 30°C while shaking at       
200 rpm. Ensure that you avoid opening and closing the closing the incubator until 
incubation period has elapsed. 
 
 
DAY 5 
 
VII. Measurement of optical densities (Endpoint): 
 
1) Aliquot the amount of Z-buffer you will need into a 250 mL screw top bottle. You 
will need about 50 mL of Z-buffer per assay plate. Add 135 L of βME per 50 mL 
of Z-buffer and mix thoroughly.   
 
2) Prepare o-NPG assay buffer: NOTE: Do not allow o-NPG to cool down to room              
temperature before use. Use as soon as you remove from freezer and return                  
immediately. For each assay plate, dissolve 42 mg of o-NPG in 41 mL of the                      
freshly-prepared Z-buffer + βME. o-NPG takes approximately 30 to 35 minutes to  
dissolve. Once dissolved, add 1 mL 10% SDS and an additional 525 µL of βME.   
Mix the contents of this solution thoroughly. 
 
3) Using a multichannel pipettor, add 50 L of Z-buffer (NOTE: Plain Z-buffer +       
βME and not the assay buffer) to each well of the 96 deep well 1 mL plate.             
Replace the plate sealing film on the plate if you observe any vapors or liquid on it. 
Mix the plate’s contents at room temperature by shaking at 300 rpm for                 
3-5 minutes on a shaker table. 
 
4) Remove the plate sealing film and use a multichannel pipettor to add 400 L of the 
o-NPG assay buffer to each well. NOTE: Ensure that no bubbles are present in  the 
pipette tips and each has the same level of o-NPG assay buffer. Reseal the  well wit
h the same plate  sealing film.  
 
5) Incubate the plate at 30C for 20 minutes while shaking at 200 rpm. 
 
6) Using a multichannel pipettor, add 200 L of 1 M sodium carbonate to each well to 
stop the reaction. 
 
7) Centrifuge the plate at room temperature for 10 minutes at 3000 rpm in order to       
allow the yeast cells settle to the bottom of the 96 deep well 1 mL plate. 
 
8) Using an 8 channel multipipettor, withdraw 100 L of clear supernatant from each 
well and place on a sterile 96 well flat bottom microplate. Ensure that you do not wi
thdraw any yeast cell debris during this step. Avoid allowing bubbles in the 96 well 
flat bottom microplate because they will interfere with the plate reader’s result. 
 
9) Measure the absorbance of the contents of the plate above at 450 nm by using a      
plate reader. Export the 450 nm measurements into an excel spreadsheet and            
transfer the spreadsheet into a USB drive. Proceed to calculations below (See part  
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V of this protocol).  Once the data analysis is complete and you are sure that you do   
not need to re-measure the absorbance of the samples at 450 nm, proceed to step 11. 
 
10) Using a multichannel pipettor, thoroughly mix the contents of the 96 deep well            
1 mL plate so that the yeast cells are resuspended in the wells. 
 
a) Using a multichannel pipettor, mix the contents of column 12 by aspirating each 
well about 10 to 15 times. 
 
b) Transfer 100 L of the contents of column 12 into a sterile 96-well flat bottom              
microplate. 
 
c) Push the top of multichannel pipettor’s button so that the contents of the pipette  
tips are discarded on a Kim wipe. Continue this process until no bubbles are       
visible on the pipette tips. Repeat the process again for column 11 and work your 
way to column 1.  
  
11) Measure the absorbance of the plate (in step 10) containing the resuspended yeast    
solution at 600 nm and place raw readings under template 4 that is set up exactly as 
template 2 under part V of this protocol. Compare the samples absorbance at 600    
nm to that of the negative control’s average. Values that are 10% less than that of    
the negative control’s average are taken as indication of cytotoxicity to the yeast     
cells due to the presence of the sample. Such cytotoxic concentrations are excluded 
from the data set used to plot the dose response curves for estrogenic activity.   
 
 
Clean up: 
 
1) All plates and disposable containers that have been inoculated with yeast cells should 
be autoclaved prior to disposal. 
 
2) All glassware should be cleaned according to the glassware cleaning procedure,        
wrapped with aluminum foil and stored in their appropriate cabinet. 
      Pour unused assay media, and chemicals into properly labeled disposal container and 
store appropriately according to laboratory procedure. 
 
VIII.    Yeast Estrogen Screen Calculation Procedure to Determine EC50 for  4-nonylphenol  
            Calibration Curve 
 
For the calibration curves, you should have two rows (A & B) containing 11  
concentrations of nonylphenol, ranging from a pre-dilution concentration of 2.50E-03 M  
to 2.44E-07 M. Remember that you added 100 µL of the nonylphenol standard to the  
wells before diluting it with 300 µL of yeast suspension; therefore, the actual final  
concentrations/concentration factors are the pre-dilution concentrations divided by 4.  In  
your calculations nonylphenol concentrations will range from 6.24E-05 to 6.09E-08 M. 
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Label an excel spreadsheet as shown below: 
 
Template 1: 
 
Column A: Labeled as compound with the corresponding samples listed as ran on the  
YES assay plate. 
 
Column C: Labeled as absorbance at 450 nm  
 
Column N: Labeled as negative control 
 
Column P: Labeled as average of negative control 
 
1) Transfer the raw absorbance readings into template 1 of the excel spreadsheet. The 
highest absorbance for nonylphenol should be at cells C2 and C3. 
 
2) Average the absorbance 450 nm (Abs450) of the negative controls in order to get a 
single negative control value.  
 
3) Leave some spaces after template 1 and set up template 2 (in the same format as 
template 1 but exclude column P) on the same page of the excel spreadsheet. 
Template 2 will contain your corrected absorbances for E2, and samples. 
 
4) Template 2: For each well on the plate, subtract the single Abs450 of the negative 
control from Abs450 of sample. This value (Abs450 of sample – Average Abs450 of 
negative control) will   simply be referred to as “Abs 1” and “Abs 2”. 
 
5) Leave some spaces after template 2 and set up template 3 (as shown below) on the 
same page of the excel spreadsheet in order to plot the dose response curve for 
nonylphenol and samples. 
 
Template 3: Columns may vary based on how you want your sheet set up. 
 
Column A: Concentration. 
 
Column B: Abs 1. 
 
Column C: Abs 2. 
 
You have 2 absorbances since each sample was run on 2 rows during the assay. 
Column D: % Induction 1. 
Column E: % Induction 2. 
 
Column F: Top. 
 
Column G: Bottom. 
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Column H: EC50. 
 
Column I: Lower 95
th
 % confidence interval for EC50. 
 
Column J: Upper 95
th
 % confidence interval for EC50. 
 
Column K: Hillslope. 
 
Column L: EC10. 
 
6) Transfer the E2 concentrations into column A of template 3 with the highest 
concentration being on top. 
 
7) Transfer the corrected absorbances at 450 nm into column B and C of template 3 and 
proceed to Appendix B.  
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APPENDIX B: Yeast Androgen Screen (YAS) Assay Protocol 
 
Part 1: Materials needed 
 
96 well plate reader* (Molecular Devices, EMAX; Sunnyvale, California) 
Shaker table** (Barnstead International; Dubuque, Iowa) 
Incubator** (Fisher Scientific; Dubuque Iowa) 
Weighing scale (Sartorius; Goettingen, Germany) 
Stirrer (Barnstead/Thermolyne; Dubuque, Iowa) 
Disposable filter sterilization flasks (Corning Incorporated; Corning, New York) 
Disposable (100 x 15 mm) sterile petri dishes (Fisher Scientific; Suwanee, Georgia) 
Disposable 96 well flat bottom microplates (Greiner-Bio-One; Frickenhausen, Germany) 
Disposable 96 deep well 1 mL plates (Fisher Scientific; Suwanee, Georgia) 
Falcon tube (Becton Dickinson Labware, Franklin Lakes, New Jersey) 
Plate Sealing Film (Denville Scientific; Metuchen, New Jersey) 
Disposable V-shaped wells for multichannel pipetting (USA Scientific; Ocala, Florida) 
Vortex mixer (Barnstead/Thermolyne; Dubuque, Iowa) 
Original potable pipette aid (Drummond Scientific; Broomall, Pennsylvania) 
50 – 300 µL 8 multichannel  pipettor: 50 – 300 µL (Thermo Labsystems; Vantaa, Finland) 
2 – 20 µL 12 multichannel pipettor: 2 – 2 µL (Rainin; Columbus, Ohio) 
100 – 1000 µL pipettor (Fisher Scientific; Dubuque, Iowa) 
Disposable (1 – 250 µL)  pipette tips  (Fisher Scientific; Suwanee, Georgia) 
20 -100 µL pipettor (Pipetman; Middleton, Wisconsin) 
Weighing paper: 152 x 152 mm (Fisherbrand; Suwanee, Georgia) 
1L reusable media/solution glass bottles (Corning Incorporated; Corning, New York) 
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250 mL screw cap Erlenmeyer glass flask (Kimble Chase Kontes; Vineland, New Jersey) 
1, 5, 10 and 25 mL plastic disposable pipettes (Fisher Scientific; Raleigh, North Carolina) 
 
*Located in room *2104 and **1213 
 
Part 2: Chemicals Needed 
Chemical                    CAS                    Brand/Source used by Weinberg lab 
a
KH2PO4     7778-77-0             Fisher Scientific: Fair Lawn, NJ 
Ammonium sulfate    7783-20-2  Mallinckrodt; Paris, KY 
b
KOH      71769-53-4  Fisher Scientific; Fair Lawn, NJ 
Casamino acids    65072-00-6  Fisher Scientific; Fair Lawn, NJ 
Adenine     73-24-5  Alfa Aesar; Ward Hill, MA 
Bacto agar     2014-03-31  BD; Sparks, MD 
c
Fe2(SO4)3     10028-22-5  MP Biomedicals; Santa Ana, CA 
D (+) Glucose     50-99-7  Fluka; St. Louis, MO 
L-aspartic acid
 
    56-84-8  MP Biomedicals; Santa Ana, CA 
L-threonine     72-19-5  Acros Organics; New Jersey, NJ 
d
MgSO4 * 7H2O    10034-99-8  Acros Organics; New Jersey, NJ 
e
CuSO4 * 5H2O    7758-98-7  Sigma Aldrich; St. Louis, MO 
f
CPRG      99792-79-7  Sigma Aldrich; St. Louis, MO 
Thiamine     59-43-8  Sigma Aldrich; St. Louis, MO 
Pyridoxine     65-23-6  Sigma Aldrich; St. Louis, MO 
D-pantothenic acid hemicalcium salt  137-08-6  Sigma Aldrich; St. Louis, MO  
Inositol     87-89-8  Acros Organics; New Jersey, NJ 
Biotin      58-85-5  Kodak; Rochester, NY 
a
KH2PO4: Potassium dihydrogen phosphate 
b
KOH pellets: Potassium hydroxide  
c
Fe2(SO4)3: Iron (III) sulfate 
d
MgSO4 * 7H2O: Magnesium sulfate septahydrate 
e
CuSO4 * 5H2O: Cupric sulfate pentahydrate 
f
CPRG: chlorophenol red-β-D-galactopyranoside 
 
 
Part 3: Preparation of solutions and buffers 
Minimial Medium (1L) + L-Aspartic acid + L-Threonine 
- Dissolve the following components in 1L LGW 
- 13.61 g KH2PO4 
- 1.98 g (NH4)2SO4 
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- 4.2 g KOH pellets 
- 0.2 g MgSO4 
- 6.72 g casamino acids 
- Add 1 mL of 10 mg/L/12.5 mL Fe2(SO4) (prepared just before making the media),       
27.4 mL L-Aspartic acid solution and 8.7 mL L-Threonine solution 
 
- Filter sterilize using a disposable filter sterilization unit and store at room temperature. 
 
 
L-Aspartic acid solution (4 mg/mL) for the assay medium 
- Dissolve 0.120 g L-Aspartic acid in 30 mL of LGW 
- Filter sterilize using a disposable filter sterilization unit and store at room temperature. 
 
 
L-Threonine solution (24 mg/mL) for the assay medium 
- Dissolve 0.240 g L-Threonine in 10 mL of LGW 
- Filter sterilize using a disposable filter sterilization unit and store at room temperature 
 
 
D (+) Glucose (20% solution) for the preparation of the growth media 
- Dissolve 40.00 g glucose in 200 mL LGW 
- Filter sterilize using a disposable filter sterilization unit and store at room temperature 
 
 
Copper (II) sulfate (20mM) for the preparation of the growth media 
- Dissolve 0.128 g copper (II) sulfate in 40 mL LGW 
- Filter sterilize using a disposable filter sterilization unit and store at room temperature 
 
 
 
 
Vitamin solution for the preparation of the growth media 
- Using a microbalance, weigh out the following: 
- 8 mg thiamine 
 
 
100 
 
- 8 mg pyridoxine 
- 8 mg pantothenic acid 
- 40 mg inositol 
- Dissolve in 180 mL of LGW 
- Add 20 mL biotin (2 mg/100 mL LGW) 
- Filter sterilize using a disposable filter sterilization unit and store at 4°C 
 
Chlorophenol red-β-D-galactopyranoside (CPRG) 
- Dissolve 0.01 g CPRG in 1 mL of LGW and store at 4°C 
 
 
Growth media for yeast culture 
- Add 23.8 mL assay medium (minimal media + L-Aspartic acid + L-Threonine), 2.5 mL 
glucose, 0.25 mL vitamin solution and 63 µL CuSO4 to a 50 mL falcon tube and vortex.  
 
 
Preparation of solid agar plates for yeast cell propagation 
- Add 1 g bacto agar per 100 mL assay medium. Autoclave at 121°C for 15 minutes. Allow 
to cool to 50°C, then add 10.5 mL glucose, 1.1 mL vitamin solution and 265 µL CuSO4 
per 100 mL assay medium.  
 
- Add 15-20 mL of agar solution to each petri dish and allow solution to cool. Seal plates 
with parafilm and refrigerate at 4°C.  
 
Part 4: Yeast Cell Propagation and Assay Procedure: 
1.  Yeast cell propagation 
I. Cell growth on solid growth media: 
The procedure is followed as in the YES assay, except that growth media is used instead 
of Ura-Trp media. 
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2. Assay Procedure 
 
NOTE:  Slightly different procedures must be followed depending on whether  
samples are prepared in 12 or 100% ethanol and other solvents.  See details below  
based on the solvents in which your samples are prepared. 
 
DAY 1 
II.        Grow yeast cells in growth media: 
1) Aliquot 7 mL of growth media into a 50 mL sterile falcon tube.  
 
2) Using a sterile wand, pick up one independent colony from a solid agar plate and              
transfer it to the liquid media in the falcon tube. 
 
3) Incubate the yeast cells at 30C on a shaker table at 200 rpm for 48 hours. 
 
 
DAY 3 
III.        Determination of yeast cell density and its dilution using growth media: 
1) Vortex the falcon tube containing the 24 hour yeast suspension culture by using a 
vortex mixer. Ensure that the 96 well plate reader is turned on at least 10 minutes 
prior to use. 
 
2) Plate 100 L (in triplicate) of the yeast suspension on 96-well flat bottom            
microplate. Also plate 100 μL (in triplicate) of the growth media on the same        
plate.  Read the plate at an absorbance of 620 nm in a plate reader. 
 
3) Calculate the total volume of yeast cell solution that is used for each set of            
experiments: 
 
a) Subtract Abs620growth media from Abs620Yeast 
 
b) Solve for x:  (Abs620Yeast – Abs620growth media)(x μL) = (0.15)(100 μL) 
 
4) Solve for y:  (x μL)/(100μL) = (y mL)/25 mL) 
 
5) y mL of yeast + (25-y) mL of growth media = dilution of the yeast suspension      
needed for the assay. 
 
6) Make the yeast dilution calculated above. In order to ensure that there is enough  
yeast solution; make 25 mL of diluted yeast suspension per YAS plate.  
 
7) Check your yeast dilution to make sure that the Abs620 falls in the range of 0.15    
and 0.20 (Once again, subtract Abs620growth media to account for background). 
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8) Add 500 L of CPRG solution per 50 mL to the diluted yeast solution and vortex 
to mix. 
 
IV.       Prepare assay plates:  
 
 NOTE: The preparation of the plates depends on what samples are being tested. If  
DBPs are being tested, the positive control is 4-nonylphenol (4.54E-03 M) in 12% 
EtOH. If water samples are being tested, the positive control is 4-nonylphenol (6.81E-
03 M) in 100% EtOH. If non-volatile standards are being tested, the positive control 
is 4-nonylphenol (4.54E-03 M) in 100% EtOH. 
         
1) For samples prepared in 100% EtOH: Using a multichannel pipettor, add 100 L 
of 100% ethanol to each well in columns 12-2 of a 1 mL 96 deep well plate. 
 
2) For samples prepared in 12% EtOH: Using a multichannel pipettor, add 100 μL of 
12% EtOH to each of the wells in column 12-2 of a 96 well flat bottom plate. 
 
3) For samples prepared in 100% EtOH: Add 200 µL of positive control                    
(4.54E-03 M) to the first column of rows A and B (Wells A1 and B1). Add          
200 µL of positive control (6.81E-03 M) to row C-H. 
 
4) For samples prepared in 12% EtOH: Add 200 µL of positive control to the first    
column of rows A and B (Wells A1 and B1). Add 200 µL of sample in                 
12% EtOH, in duplicate, to the first wells in rows C-H. 
 
5) Using a multichannel pipettor, dilute each column serially in 1:2 dilutions.            
(Transfer 100 μL of sample from column 1 to column 2; mix thoroughly by          
aspirating, then transfer 100 μL from column 2 to column 3. Continue the serial    
dilution across entire plate until   you get to column 11. After mixing the contents 
of column 11, withdraw 100 uL that would be discarded as waste so that the         
column 12 wells containing the negative control as shown in the YAS assay          
template (Figure B.1) has only ethanol at this point. 
 
6) For samples prepared in 100% EtOH: Remove 10 µL aliquots from the 96 well     
deep  well plate and add to the wells in the same position on a 96 well flat bottom 
plate. Allow the EtOH to evaporate completely in a hood. Cover the plate loosely 
with a Kim wipe.  
 
7) If water samples are being tested, add 100 µL LGW to each of the wells in two     
rows containing 6.81E-03 M nonylphenol as the highest concentration. This is the                    
experimental positive control. Add 100µL of water sample being tested to the       
other rows, in duplicate.  
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V.         Exposure of yeast cell to samples: 
1) Add 200 μL of the yeast/CPRG solution to each well of the 96 deep well 1 mL 
plate containing the samples, nonylphenol and negative control. Ensure that you 
perform this addition by starting from column 12 which contains the negative 
control. Ensure that each pipette has the same level of diluted yeast solution and 
no bubbles prior to placing in wells. 
 
2) Cover plate with a plate sealing film and incubate at 30°C while shaking at      
~200 rpm for 3 minutes. Remove the plate from the shaker and leave in the 
incubator for 24 hours. Ensure that you avoid opening and closing the closing the 
incubator until incubation period has elapsed. 
 
 
DAY 4 
 
VI. Measurement of optical densities (Endpoint): 
  
1) Measure the absorbance of the plate at 540 and 620 nm. Calculate the corrected               
absorbance as the difference between the chemical absorbance at 540 nm and the 
value obtained when the blank absorbance at 620 nm is subtracted from the          
chemical absorbance at 620 nm. The dose-response curves were obtained by        
plotting the corrected absorbance against the sample concentrations. 
 
2) Compare the samples absorbance at 620 nm to that of the negative control’s         
average. Values that are 10% less than that of the negative control’s average are    
taken as indication of cytotoxicity to the yeast cells due to the presence of the       
sample. Such cytotoxic concentrations are excluded from the data set used to plot 
the dose response curves for androgenic activity.   
 
3) Prepare the data similar to that in Appendix A. 
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APPENDIX C: Preparation of Standard Solutions 
 
 
1.    4-nonylphenol stock solution in 100% EtOH (5 mL): The target concentration is   
       approximately 10000 mg/L 
 
Prepare this solution on a weighing balance. 
a) Add ethanol to a 5 mL volumetric flask  
b) Spike in 60 µL of 4-nonylphenol standard (record the weight before and after   
spiking in nonylphenol) 
 
c) Fill to the 5 mL line with ethanol. Invert 3 times to mix. 
Use the weight of 4-nonylphenol added to determine the exact concentration of the 
stock solution. 
 
1. 4-nonylphenol primary dilution in 100% EtOH (5 mL): The target concentration is 
approximately 1000 mg/L (4.54E-03 M) 
(This solution is used as the positive control for the YAS method) 
 
a) Add ethanol to a 5 mL volumetric flask 
b) Spike in approximately 440 µL of the nonylphenol stock solution prepared 
above (be sure to record the volume added so that an exact concentration may 
be obtained) 
 
c) Fill to the 5 mL line with ethanol. Invert three times to mix. 
2. 4-nonylphenol working solution in 10% EtOH (2 mL): The target concentration is 
approximately 55 mg/L (2.50E-04 M) 
(This solution is used as the positive control for the YES method) 
 
a) Add LGW to a 2 mL volumetric flask 
b) Determine how much of the nonylphenol primary dilution solution will be 
needed to obtain the desired concentration (it should be approximately        
110 µL) 
 
c) In order to obtain a 10% ethanol solution, a total of 200 µL of ethanol must be 
added; therefore, 90 µL of 100% ethanol should be spiked into the flask as 
well. 
 
NOTE: If the working solution is prepared in another matrix, substitute this matrix for 
the LGW. 
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3. 4-nonylphenol primary dilution in 100% EtOH (5mL): The target concentration is 
approximately 1500 mg/L (6.81E-03 M) 
(This solution is used as the experimental positive control for YAS) 
 
a) Add ethanol to a 5 mL volumetric flask 
 
b) Spike in approximately 750 µL of the nonylphenol stock solution prepared 
above (be sure to record the volume so that an exact concentration may be 
obtained) 
 
c) Fill to the 5 mL line with ethanol. Invert three times to mix.  
 
 
4. Preparation of DBP stock solution in 100% EtOH (5mL): The  target concentration is 
approximately 10000 mg/L 
 
a) Add ethanol to a 5 mL volumetric flask 
 
b) Add the appropriate volume or weight of standard required (record the exact 
weight added) 
 
c) Fill to the 5 mL line with ethanol 
 
Prepare the primary dilution and the working solution similar to how the nonylphenol  
solutions are prepared. 
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APPENDIX D: Standard Operating Procedure for Total/Dissolved Organic Carbon 
(TOC/DOC) in water samples 
 
The instrument used is a Shimadzu TOC-VCPH Total Organic Carbon Analyzer (Shimadzu  
Corp., Atlanta, GA) 
 
Standards Preparation 
 
Dissolved Organic Carbon (DOC) Stock Standard (1,000 mg/L as C) 
 Dissolve 2.125 g Potassium Hydrogen Phthalate in 1-L lab grade water (LGW); mix 
with a magnetic stir bar 
 
 Store in fridge in amber bottle with PTFE-lined septa/cap. Good for 2 months 
 
Total Nitrogen (TN) Stock Standard (1000 mg/L as N) 
 Dissolve 7.219 g Potassium nitrate in 1-L LGW; mix with a magnetic stir bar 
 
 Store in fridge in amber bottle with PTFE-lined septa/cap. Good for 2 months 
 
HCl solution (2 N)  
 Carefully add 41 mL concentrated HCl (12.1 N) to LGW in a 250 mL volumetric 
flask.  
 
 Fill to line with LGW and carefully invert 3 times. Store in amber bottle with PTFE-
lined septa/cap. 
------------------------------------------------------------------------------------------------------------ 
DOC Working Solution (100 mg/L as C) 
 Pipette 10-mL of DOC Stock Standard into a 100 mL volumetric flask; fill to line 
with LGW; invert stoppered flask three times 
 
 Store in fridge in amber bottle with PTFE-lined septa/cap. Good for 1 week 
 
DOC/TN Working Solution (100 mg/L as C, 100 mg/L as N, 0.05 M HCl) 
 Pipette 10-mL of DOC Stock Standard, 10 mL of TN Stock Standard, and 2.5 mL of 
2 M HCl into a 100 mL volumetric flask; fill to line with LGW; invert stoppered flask 
three times 
 
 Store in fridge in amber bottle with PTFE-lined septa/cap. Good for 1 week 
------------------------------------------------------------------------------------------------------------ 
Calibration Points should be made fresh for every run 
 To make 0.5 mg-C/L Calibration Point, pipette 0.5 mL of DOC Working Solution 
into a 100-mL volumetric flask; fill to line with LGW; invert stoppered flask three 
times 
 
 Additional Calibration Points are made in an analogous fashion 
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Procedure 
 
Notes: 
*The concentrations of the samples need to be less than 10 mg/L as C or N – you should  
first test a highly diluted sample to make sure you will be in the correct range. 
*If you do not plan to analyze your water samples soon after you collect them, adjust to  
pH 4.5 and store them in the fridge. 
*Before you start running samples, you need to talk to person in charge of the TOC/TN  
about what type of samples you will be running – to make sure they will not compromise  
the instrument 
 
1. Prepare calibrations (for example: 0, 0.5, 5, 10 mg C and N/L) and samples (dilute if  
    necessary – concentration needs to be less than 10 mg/L as C or N). 
 
2. Pour your samples and calibrations into acid-washed TOC vials. 
 
3. Acidify all samples and calibrations to pH 2-2.5 using 2 N HCl. A typical surface  
    water requires about 2-4 drops of 2 N HCl if using 24 mL sample vials, but you need  
    to test your actual sample matrix using a pH meter to be sure you adjust the pH to this  
    value. Cover each vial with aluminum foil. Calibration points prepared using LGW  
    from Weinberg lab typically require ~6 drops of 2 N HCl per 100 mL (but you should  
    check the pH using an extra aliquot with the pH meter).  
 
4. Start the system: Before using the instrument, check a day or two in advance that the  
    head pressure on the air tank is above 500psi by opening the regulator attached to the  
    air tank and reading the pressure. If it is not, consult with whoever is responsible for  
    the instrument so that a new gas tank can be ordered. Use only UHP air (“air grade  
    zero”). On the day of use turn on computer, turn on TOC analyzer, and open the air  
    tank at the regulator.  
 
5. Check the system:  
    Open Software (TOC ControlV) 
    Sample table (User = TOC; password = UNC) 
    File  New  sample run  (TC/IC-TN 24mL system (default) or use TC/IC-TN  
    40mL if using 40 mL sample vials) 
    Instrument  connect  
    Check the following on the instrument: 
(a) Carrier gas flow  = 150 (TOC analyzer) 
 
(b) Pressure = 200 (TOC analyzer) 
 
(c) Continuous bubbles in the plastic bottle (TOC analyzer) 
 
(d) N flow ~ 0.5 (Nitrogen unit) 
 
(e) Fill the humidifier tank with laboratory grade water (LGW) of TOC < 0.5ppm water if it 
is empty or almost empty. 
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    Instrument  Background monitor  run and wait for all points to be checked and  
    Green (about 20 mins) 
 
6. Create your calibration curve 
    For TOC/DOC: 
    File  New  Calibration curve  24mL system (default)  NPOC (for Non  
    Purgeable  
    Organic Carbon) 
    Standard 
    TOC 
    Linear Regression (uncheck the ‘zero shift’) 
    Check ‘multiple injections’ 
    Put the number of standards and the range of the concentrations 
    Adjust the concentrations of each standard and save 
 
    For TN: 
    File  New  Calibration curve  24mL system (default)  TN Standard 
    TN 
    Linear Regression (uncheck the ‘zero shift’) 
    Check ‘multiple injections’ 
    Put the number of standard and the range of the concentrations 
    Adjust the concentrations of each standard and save 
 
7. Create your sequence 
(a) First excel cell  insert autogenerate choose your method  put 3-4 blank  
            LGW vials to rinse the system 
 
(b) Run a 5 mg/L as C and N standard after LGWs. You will record the area counts  
            for these in the logbook and do the same for a 5 mg/L as C and N standard at the  
            end of your run. 
 
(c) Click on next excel cell  insert calib curve NPOC  enter the vial #s in the ASI  
      vial view 
 
(d) Next excel cell  insert calib curve TN  enter the vial #s 
 
(e) Next excel cell  insert auto generate  choose your method  enter the number  
      of samples and start vial # (only after the standards)  Enter your sample name in   
      the excel cells Save as your sequence 
            *be sure to run another 5 mg/L as C and N standard after all of your samples and   
            a LGW blank.  
            Run 3 LGW blanks after this standard too. 
 
8.   Check the system: Recheck the previous signals, if all lights are green, 
      Maintenance  replace flow line content (cleans the syringe) 
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9.   Run the sequence 
      Instrument  Start  Shut down  make sure external acid addition is checked  run 
 
10. Instrument will shut down once sample run is finished, but you need to come in and  
      manually turn off the gas tank at the regulator when run is done. 
 
 
11. In the notebook by the instrument, record the method and calibration you used next to 
your name and the date. When your samples have finished running, record the calibration 
curve information: slope, y-intercept, R
2
, and the area counts for the first non-zero 
calibration point area. Also record the area counts for the 5 mg/L standards at the start 
and end of your run. 
 
12. After running your samples, remove vials from instrument immediately and clean them. 
Any vial containing environmental samples (tap water or dirtier) needs to be rinsed and 
put in the 10% nitric acid bath overnight. Then rinse at least 3x with LGW and dry in 
180
o
C oven overnight. Any vial containing LGW or standards made up in LGW can be 
rinsed 3x with LGW and dried in 180
o
C oven overnight. 
 
13. Maintenance – All users are expected to contribute their time in maintaining the 
instrument, troubleshooting problems, and providing resources to replace consumables. 
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APPENDIX E: Standard Operating Procedure for Standardization of Sodium 
Hypochlorite (NaOCl) 
 
Prepared by Katja Kritsch, 2010. 
 
The instrument used to measure chlorine residuals is a Hach Chlorine Pocket Colorimeter  
and the DPD reagent powder pillows (Hach Co., Loveland, CO) 
 
 
The hypochlorite stock solution comes ready to use and does not need to be diluted. 
However, the actual free chlorine concentration in mg/L as Cl2 is usually not known. The 
hypochlorite solution needs to be standardized prior to use according to procedure 4500 Cl 
B. Iodometric Method I in Standard Methods for the Examination of Water and 
Wastewater, 20
th
 edition. If the concentration was determined within the past 4 weeks, it is 
acceptable to use a previously titrated solution. 
 
5. Standardization of the Free Chlorine Stock Solution 
 
a)    Place the small funnel on top of the burette and fill burette to the zero mark  
   with 0.01 N sodium thiosulfate titrant prepared and standardized according     
   to procedure 4500 Cl B. Iodometric Method I in Standard Methods for the   
   Examination of Water and Wastewater, 20
th
 edition. Either the iodate or the   
   dichromate method can be used for this standardization. 
 
b)    Add 2 mL of the NaOCl stock to a 100 mL volumetrick flask and dilute to      
         the mark with LGW. 
 
c)    Add 40 mL of the chlorine working solution, prepared above, to a 125 mL   
   Erlenmeyer flask. Adjust the pH to between 3.0 and 4.0 using glacial acetic   
   acid (this would require approximately 10 drops).  
  
d)    Add 1 g potassium iodide (the solution should turn brown). 
 
e)    Titrate with 0.1N sodium thiosulfate (Na2S2O3) until a pale yellow colored   
   solution forms. 1 mL of starch solution was then added to the flask. 
 
f)    Titrate the resulting dark purple solution with 0.1N Na2S2O3 until the    
         solution turns colorless. 
 
g)    Determine the concentration of the NaOCl stock solution using the   
   following equation: 
 
)40(
)2/100(*)/1000)(/450.35(*)1.0(*)(
/ 23223222
titratedsamplemL
ClmLLGWmLgmgmolClgOSNaNtitrationinusedOSNamL
ClasLmg 
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APPENDIX F: Preparation of Monochloramine Dosing Solution 
 
Prepared by Maria José Farré, 2008. 
 
The instrument used to measure monochloramine residuals is the Hach DR/890 Datalogging  
Colorimeter with the monochlor-F reagent powder pillows (Hach Co., Loveland, CO) 
 
1. Solution A: 24 mM aqueous  ammonium chloride 
 
a)    Dissolve 0.6418 g ammonium chloride in 500 mL of LGW and adjusting the  
   pH to 8.0 by adding NaOH (0.5 M) 
 
b)    Chill to 5°C 
 
2. Solution B: 20 mM monochloramine stock solution (N:Cl 1.2:1 molar ratio) 
 
Monochloramine solution must be prepared daily. 
 
a) Determine the amount of free chlorine in the NaOCl solution by using the 
procedure in  Appendix D.  
 
b) Calculate the corresponding amount of NaOCl to be added to 100 mL of 
solution A in a molar ratio N:Cl 1.2:1 
 
c)  
 
2
2
1001400
)( 2
ppmCl
Cl
measured
mLClppm
mLV


 
Where 1400 ppm Cl2 is 20 mM NaOCl, which is the 0.8% or the 24 mM ammonium  
chloride solution 
 
d) Add corresponding volume to solution A slowly to a rapidly stirred solution. 
The adjustment of the pH to 8 and the slow addition is necessary in order to 
avoid dichloramine formation.  
 
e) Dilute the monochloramine stock solution 1:20 with LGW and measure the 
absorbances at 245 and 295 nm using a Hitachi U-3300 UV-vis 
spectrophotometer (Hitachi, Tokyo, Japan). Given a path length (l) of       1 
cm and molar absorptivity values (ε) for monochloramine and dichloramine at 
each of the wavelengths, the concentrations of monochloramine (c1) and 
dichloramine (c2) were calculated using simultaneous equations (one for each 
wavelength) in the following equation: 
 
)()()( 2211  lclcA   
f) Store the final chloramine stock solution at 4°C until use on the same day. 
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APPENDIX G: Instructions for Working with YES Data in Graphpad Prism 4.03 
 
1. Using the corrected absorbances in rows B and C; plot Abs 1 and Abs 2 as a function of 
the log of molar concentration of E2 using the Graphpad Prism 4.03 graphing program: 
 
a) In Prism, select “XY” graph, and select “2” as the number of replicates. 
 
b) In the data sheet, enter the E2 concentrations as the X values, and corresponding 
Abs as the Y values. 
 
 
c) Go to the graph.  Click “Analyze”, “Data manipulations”, select “Transform”, and 
select “Transform X values X=Log(X)”.  This will log transform the X-axis. 
 
2. Fit the data points to a sigmoidal dose-response curve: 
 
a) Go to the graph of your E2 standard curve titled, “Transform of Data 1 graph”. 
 
b) Click “Analyze”, select “Curves and Regressions”, followed by “Nonlinear 
regression (curve fit). Click “OK”. Select “Sigmoidal dose response (variable 
slope)” and click “OK”. Label the X axis as the log of molar concentration and 
the Y axis as the corrected absorbance. 
 
3. Find the Top (maximum) and Bottom (minimum) points of your standard curve. 
 
a) Go to the Results section for your E2 standard curve. 
 
b) You will see the “Top” and “Bottom” points listed. 
 
4. Calculate percent induction for each E2 concentration, using the equation:    % 
Induction =

AbsBottom 
TopBottom 
100   
 
5. Plot the percent induction as a function of log [E2] with GraphPad Prism: 
 
 
a) On a new data sheet, enter the E2 concentrations as the X values, and 
corresponding percent inductions as the Y values. 
 
b) Log transform the curve:  Go to the graph, click “Analyze”, select “Transforms”, 
and select “X=Log(X)”.   
 
 
c) Fit a sigmoidal curve:  Click “Analyze”, select “Curves and Regressions”, and 
select “Sigmoidal curve (variable slope)”.  On the “Constraints” tab, set “Top = 
“100” and “Bottom = “0”. 
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6. Find the hillslope and EC50 under Results.  These numbers will be used to calculate the 
EEQ for the samples: 
 
a) Go to the Results section for the standard curve. 
 
b) You will see “Hillslope” and “EC50” values listed. 
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APPENDIX H: Instructions for Working in R and Calculation of p-values 
1) In an Excel worksheet, set up the data as follows and save as a “csv” file. In this  
worksheet, ‘lconc’ is the log molar concentration, ‘absm’ is the average absorbance  
value and ‘trt’ represents the solution in which the 4-nonylphenol is prepared. 
 
lconc absm trt 
-
4.20E
+00 
0.9794 10%EtOH 
-
4.51E
+00 
0.8539 10%EtOH 
-
4.81E
+00 
0.8494 10%EtOH 
-
5.11E
+00 
0.9079 10%EtOH 
-
5.41E
+00 
0.8209 10%EtOH 
-
5.71E
+00 
0.7384 10%EtOH 
-
6.01E
+00 
0.3859 10%EtOH 
-
6.31E
+00 
0.1544 10%EtOH 
-
6.61E
+00 
0.0394 10%EtOH 
-
6.91E
+00 
0.0179 10%EtOH 
-
4.20E
+00 
0.8254 10%EtOH/acet 
-
4.51E
+00 
0.8079 10%EtOH/acet 
-
4.81E
+00 
0.8644 10%EtOH/acet 
-
5.11E
+00 
0.7669 10%EtOH/acet 
-
5.41E
+00 
0.6094 10%EtOH/acet 
-
5.71E
+00 
0.3239 10%EtOH/acet 
-
6.01E
+00 
0.1169 10%EtOH/acet 
-
6.31E
+00 
0.0384 10%EtOH/acet 
-
6.61E
+00 
0.0054 10%EtOH/acet 
-
6.91E
+00 
0.0004 10%EtOH/acet 
 
2) In the R program, go to ‘Change dir’ to change the working directory. The directory 
would be where the worksheet is saved. 
 
3) Enter the code: “name” <- read.csv(“name of file.csv”) 
where ‘name’ is the name that the workspace file is assigned 
 
4) Enter code: attach(“name”) 
 
5) Enter code : “name”.lm <- lm(absm~lconc + trt, data = “name”) 
 
6) Enter code: summary(“name”.lm) 
 
When all dose concentrations are considered in the analysis, the following adjustments  
are made: 
 
1) After changing the directory, enter the code: library(mgcv) 
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2) Perform steps 3 & 4 
 
3) Enter code: summary(gam(absm~s(lconc) + trt, data = “name”)) 
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